CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: okadaic acid
Accession: CHEBI:44658
browse the term
Definition: A polycyclic ether that is produced by several species of dinoflagellates, and is known to accumulate in both marine sponges and shellfish. A polyketide, polyether derivative of a C38 fatty acid, it is one of the primary causes of diarrhetic shellfish poisoning (DSP). It is a potent inhibitor of specific protein phosphatases and is known to have a variety of negative effects on cells.
Synonyms: exact_synonym: (2R)-2-hydroxy-3-{(2S,5R,6R,8S)-5-hydroxy-8-[(2R,3E)-4-((2R,4a'R,5R,6'S,8'R,8a'S)-8'-hydroxy-6'-{(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undec-2-yl]butyl}-7'-methylideneoctahydro-3H,3'H-spiro[furan-2,2'-pyrano[3,2-b]pyran]-5-yl)but-3-en-2-yl]-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl}-2-methylpropanoic acid
related_synonym: 9,10-Deepithio-9,10-didehydroacanthifolicin; Formula=C44H68O13; InChI=1S/C44H68O13/c1-25-21-34(55-44(23-25)35(46)12-11-31(54-44)24-41(6,50)40(48)49)26(2)9-10-30-14-18-43(53-30)19-15-33-39(57-43)36(47)29(5)38(52-33)32(45)22-28(4)37-27(3)13-17-42(56-37)16-7-8-20-51-42/h9-10,23,26-28,30-39,45-47,50H,5,7-8,11-22,24H2,1-4,6H3,(H,48,49)/b10-9+/t26-,27-,28+,30+,31+,32+,33-,34+,35-,36-,37+,38+,39-,41-,42+,43-,44-/m1/s1; InChIKey=QNDVLZJODHBUFM-WFXQOWMNSA-N; SMILES=[H][C@]1(CC[C@@H](O)[C@]2(O1)O[C@@]([H])(CC(C)=C2)[C@H](C)\\C=C\\[C@@]1([H])CC[C@@]2(CC[C@@]3([H])O[C@]([H])([C@@H](O)C[C@H](C)[C@@]4([H])O[C@@]5(CCCCO5)CC[C@H]4C)C(=C)[C@@H](O)[C@]3([H])O2)O1)C[C@@](C)(O)C(O)=O
alt_id: CHEBI:44655; CHEBI:7733
xref: Beilstein:4640246; Beilstein:4900372; Beilstein:5471989; CAS:78111-17-8; DrugBank:DB02169; KEGG:C01945
xref_mesh: MESH:D019319
xref: PDBeChem:OKA; PMID:28429183; PMID:28476539; PMID:28648727; PMID:28755633; PMID:28817087; Reaxys:4640246
G
Aanat
aralkylamine N-acetyltransferase
decreases activity decreases expression
EXP
Okadaic Acid results in decreased activity of AANAT protein Okadaic Acid results in decreased expression of AANAT mRNA
CTD
PMID:11442772
NCBI chr10:105,568,091...105,572,407
Ensembl chr10:105,568,091...105,572,403
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases transport increases expression
ISO
ABCB1 protein results in increased transport of Okadaic Acid Okadaic Acid results in increased expression of ABCB1 mRNA
CTD
PMID:24374049 PMID:31926150
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
decreases response to substance
EXP
ABCB1B protein results in decreased susceptibility to Okadaic Acid
CTD
PMID:10494879
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Abcc3
ATP binding cassette subfamily C member 3
decreases expression
ISO
Okadaic Acid results in decreased expression of ABCC3 mRNA
CTD
PMID:31926150
NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
G
Abcg2
ATP binding cassette subfamily G member 2
increases expression
ISO
Okadaic Acid results in increased expression of ABCG2 mRNA
CTD
PMID:31926150
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ABL1 mRNA
CTD
PMID:19840844
NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
G
Aco1
aconitase 1
multiple interactions
EXP
Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of ACO1 protein]; Okadaic Acid inhibits the reaction [TRH protein results in decreased activity of ACO1 protein]; Okadaic Acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]
CTD
PMID:10889193
NCBI chr 5:56,425,076...56,481,218
Ensembl chr 5:56,425,024...56,481,218
G
Acox2
acyl-CoA oxidase 2
increases expression
ISO
Okadaic Acid results in increased expression of ACOX2 mRNA
CTD
PMID:25270620
NCBI chr15:18,449,304...18,481,472
Ensembl chr15:18,451,144...18,481,470
G
Agt
angiotensinogen
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of AGT mRNA
CTD
PMID:19840844
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
G
Akt1
AKT serine/threonine kinase 1
multiple interactions increases phosphorylation decreases phosphorylation
ISO EXP
Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of AKT1 protein]; Okadaic Acid inhibits the reaction [arsenic trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; Okadaic Acid inhibits the reaction [arsenic trioxide results in decreased phosphorylation of AKT1 protein]; Okadaic Acid inhibits the reaction [Bortezomib results in decreased expression of AKT1 protein modified form] Okadaic Acid results in increased phosphorylation of AKT1 protein Okadaic Acid results in decreased phosphorylation of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [Okadaic Acid results in decreased phosphorylation of AKT1 protein]]; Quercetin inhibits the reaction [Okadaic Acid results in decreased phosphorylation of AKT1 protein]
CTD
PMID:16059913 PMID:19261616 PMID:21655183 PMID:26437446 PMID:27050422
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of ALDH1A1 mRNA
CTD
PMID:19840844
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
increases phosphorylation
ISO
Okadaic Acid results in increased phosphorylation of ALDH1L1 protein
CTD
PMID:18000846
NCBI chr 4:123,516,553...123,564,067
Ensembl chr 4:123,516,788...123,557,501
G
Aldoa
aldolase, fructose-bisphosphate A
decreases expression
ISO
Okadaic Acid results in decreased expression of ALDOA protein
CTD
PMID:19397276
NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
G
Anapc13
anaphase promoting complex subunit 13
decreases expression
ISO
Okadaic Acid results in decreased expression of ANAPC13 mRNA
CTD
PMID:23561263
NCBI chr 8:111,107,358...111,115,774
Ensembl chr 8:111,107,358...111,115,774
G
Anxa5
annexin A5
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ANXA5 mRNA
CTD
PMID:19840844
NCBI chr 2:123,162,477...123,194,730
Ensembl chr 2:123,162,461...123,193,130
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
Okadaic Acid results in increased expression of APAF1 mRNA
CTD
PMID:31926150
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
G
Apobr
apolipoprotein B receptor
increases expression
ISO
Okadaic Acid results in increased expression of APOBR mRNA
CTD
PMID:25270620
NCBI chr 1:197,999,209...198,003,839
Ensembl chr 1:197,999,037...198,003,839
G
App
amyloid beta precursor protein
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of APP mRNA
CTD
PMID:19840844
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
G
Arhgef17
Rho guanine nucleotide exchange factor 17
multiple interactions
ISO
[calyculin A co-treated with Okadaic Acid] inhibits the reaction [2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]]
CTD
PMID:23195829
Ensembl chr 1:165,911,718...165,967,069
G
Arnt
aryl hydrocarbon receptor nuclear translocator
increases expression
ISO
Okadaic Acid results in increased expression of ARNT mRNA
CTD
PMID:28939011
NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
G
Atp5f1a
ATP synthase F1 subunit alpha
decreases expression
ISO
Okadaic Acid results in decreased expression of ATP5F1A protein
CTD
PMID:19397276
NCBI chr18:74,156,553...74,164,490
Ensembl chr18:74,156,553...74,164,495
G
Atp5f1d
ATP synthase F1 subunit delta
multiple interactions decreases expression
ISO
[Okadaic Acid co-treated with gambierol] results in increased expression of ATP5F1D protein Okadaic Acid results in decreased expression of ATP5F1D protein
CTD
PMID:19397276
NCBI chr 7:12,426,807...12,432,120
Ensembl chr 7:12,426,809...12,432,130
G
Atxn3
ataxin 3
increases expression
ISO
Okadaic Acid results in increased expression of ATXN3 mRNA
CTD
PMID:28939011
NCBI chr 6:125,817,420...125,853,461
Ensembl chr 6:125,819,640...125,853,461
G
Axin2
axin 2
increases expression
ISO
Okadaic Acid results in increased expression of AXIN2 mRNA
CTD
PMID:31115591
NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642
G
Bad
BCL2-associated agonist of cell death
decreases expression
ISO
Okadaic Acid results in decreased expression of BAD mRNA
CTD
PMID:31926150
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
G
Bak1
BCL2-antagonist/killer 1
increases expression
ISO
Okadaic Acid results in increased expression of BAK1 mRNA
CTD
PMID:31926150
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
G
Bax
BCL2 associated X, apoptosis regulator
affects localization multiple interactions increases expression decreases expression
ISO EXP
Okadaic Acid affects the localization of BAX protein Quercetin inhibits the reaction [Okadaic Acid results in increased expression of BAX protein] Okadaic Acid results in decreased expression of BAX protein Okadaic Acid results in increased cleavage of and results in increased activity of BAX protein Ursodeoxycholic Acid inhibits the reaction [Okadaic Acid results in increased expression of BAX protein]
CTD
PMID:10510466 PMID:18937299 PMID:19084044 PMID:27050422
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bbc3
Bcl-2 binding component 3
multiple interactions affects response to substance
ISO
Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased expression of BBC3 protein]]; Okadaic Acid inhibits the reaction [Estradiol inhibits the reaction [Benzo(a)pyrene results in increased expression of BBC3 protein]]; Okadaic Acid inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased expression of BBC3 protein]] BBC3 protein affects the susceptibility to Okadaic Acid
CTD
PMID:20477944 PMID:24954032
NCBI chr 1:78,261,491...78,267,802
G
Bcat2
branched chain amino acid transaminase 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BCAT2 mRNA
CTD
PMID:19840844
NCBI chr 1:101,553,900...101,572,103
Ensembl chr 1:101,554,642...101,572,080
G
Bckdha
branched chain keto acid dehydrogenase E1 subunit alpha
decreases expression
ISO
Okadaic Acid results in decreased expression of BCKDHA mRNA
CTD
PMID:25270620
NCBI chr 1:82,423,291...82,452,094
Ensembl chr 1:82,423,277...82,452,281
G
Bcl2
BCL2, apoptosis regulator
decreases expression increases expression
ISO
Okadaic Acid results in decreased expression of BCL2 protein Okadaic Acid results in increased expression of BCL2 mRNA
CTD
PMID:18937299 PMID:31926150
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l11
BCL2 like 11
increases expression
ISO
Okadaic Acid results in increased expression of BCL2L11 mRNA
CTD
PMID:28939011
NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192
G
Bcl2l14
BCL2 like 14
increases expression
ISO
Okadaic Acid results in increased expression of BCL2L14 mRNA
CTD
PMID:25270620
NCBI chr 4:168,139,964...168,183,726
Ensembl chr 4:168,142,271...168,183,096
G
Bgn
biglycan
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of BGN mRNA
CTD
PMID:19840844
NCBI chr X:157,319,042...157,331,204
Ensembl chr X:157,319,046...157,331,204
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
ISO
Okadaic Acid results in increased expression of BIRC5 mRNA
CTD
PMID:31115591
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Blvrb
biliverdin reductase B
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA
CTD
PMID:19840844
NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
G
Bpgm
bisphosphoglycerate mutase
increases expression
ISO
Okadaic Acid results in increased expression of BPGM mRNA
CTD
PMID:28939011
NCBI chr 4:61,912,210...61,940,697
Ensembl chr 4:61,912,210...61,940,696
G
Ca13
carbonic anhydrase 13
increases expression
ISO
Okadaic Acid results in increased expression of CAR13 mRNA
CTD
PMID:19000923
NCBI chr 2:88,282,961...88,314,254
Ensembl chr 2:88,282,961...88,314,254
G
Cacybp
calcyclin binding protein
decreases expression
ISO
Okadaic Acid results in decreased expression of CACYBP protein
CTD
PMID:19397276
NCBI chr13:77,948,771...77,959,089
Ensembl chr13:77,948,771...77,959,110
G
Calm1
calmodulin 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CALM1 mRNA
CTD
PMID:19840844
NCBI chr 6:124,217,241...124,225,292
Ensembl chr 6:124,217,241...124,225,292
G
Calm2
calmodulin 2
decreases expression
ISO
Okadaic Acid results in decreased expression of CALM2 mRNA
CTD
PMID:23561263
NCBI chr 6:11,067,675...11,080,078
Ensembl chr15:65,506,874...65,507,968
G
Calr
calreticulin
increases expression
ISO
Okadaic Acid results in increased expression of CALR mRNA
CTD
PMID:28939011
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
G
Canx
calnexin
increases expression
ISO
Okadaic Acid results in increased expression of CANX mRNA
CTD
PMID:28939011
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
G
Casp3
caspase 3
multiple interactions increases expression increases activity increases cleavage
EXP ISO
Norepinephrine inhibits the reaction [Okadaic Acid results in increased activity of CASP3 protein] Okadaic Acid results in increased expression of CASP3 mRNA; Okadaic Acid results in increased expression of CASP3 protein modified form Quercetin inhibits the reaction [Okadaic Acid results in increased cleavage of CASP3 protein] acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP3 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP3 protein]; Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein]]; Okadaic Acid inhibits the reaction [Estradiol inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein]]; Okadaic Acid inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein]]; Okadaic Acid results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:11099166 PMID:16954443 PMID:19084044 PMID:23335626 PMID:24954032 PMID:26732598 PMID:27050422 PMID:31926150
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp7
caspase 7
multiple interactions
ISO
Okadaic Acid results in increased cleavage of and results in increased activity of CASP7 protein
CTD
PMID:19084044
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
G
Casp8
caspase 8
multiple interactions decreases expression increases activity increases expression
ISO
acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein]; Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein Okadaic Acid results in decreased expression of CASP8 mRNA Okadaic Acid results in increased activity of CASP8 protein Okadaic Acid results in increased expression of CASP8 protein modified form
CTD
PMID:19084044 PMID:31926150
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Casp9
caspase 9
multiple interactions increases expression increases activity
ISO EXP
Okadaic Acid results in increased cleavage of and results in increased activity of CASP9 protein Okadaic Acid results in increased expression of CASP9 mRNA; Okadaic Acid results in increased expression of CASP9 protein modified form Okadaic Acid results in increased activity of CASP9 protein
CTD
PMID:19084044 PMID:26732598 PMID:31926150
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
G
Cbx1
chromobox 1
increases expression
ISO
Okadaic Acid results in increased expression of CBX1 mRNA
CTD
PMID:25270620
NCBI chr10:84,656,698...84,677,112
Ensembl chr10:84,669,914...84,675,741
G
Ccl25
C-C motif chemokine ligand 25
increases expression
ISO
Okadaic Acid results in increased expression of CCL25 mRNA
CTD
PMID:25270620
NCBI chr12:2,429,492...2,438,928
Ensembl chr12:2,429,509...2,438,817
G
Ccna1
cyclin A1
affects expression
ISO
Okadaic Acid affects the expression of CCNA1 mRNA
CTD
PMID:21512803
NCBI chr 2:144,456,689...144,503,570
Ensembl chr 2:144,458,153...144,467,912
G
Ccnb2
cyclin B2
affects expression
ISO
Okadaic Acid affects the expression of CCNB2 mRNA
CTD
PMID:21512803
NCBI chr 8:76,847,972...76,861,165
G
Ccnd1
cyclin D1
increases expression
ISO
Okadaic Acid results in increased expression of CCND1 mRNA
CTD
PMID:31115591
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Cct4
chaperonin containing TCP1 subunit 4
increases expression
ISO
Okadaic Acid results in increased expression of CCT4 mRNA
CTD
PMID:28939011
NCBI chr14:107,767,392...107,780,270
Ensembl chr14:107,767,392...107,780,270
G
Cct7
chaperonin containing TCP1 subunit 7
increases expression
ISO
Okadaic Acid results in increased expression of CCT7 mRNA
CTD
PMID:28939011
NCBI chr 4:117,235,023...117,252,265
Ensembl chr 4:117,235,023...117,252,265
G
Cd44
CD44 molecule (Indian blood group)
increases expression
ISO
Okadaic Acid results in increased expression of CD44 mRNA
CTD
PMID:28939011
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
G
Cd9
CD9 molecule
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CD9 mRNA
CTD
PMID:19840844
NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
G
Cdh1
cadherin 1
multiple interactions
ISO
Okadaic Acid promotes the reaction [CTNNB1 protein binds to CDH1 protein]
CTD
PMID:31115591
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
Okadaic Acid results in decreased expression of CDK1 mRNA
CTD
PMID:21512803
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Okadaic Acid results in decreased expression of CDK2 mRNA
CTD
PMID:21512803
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Okadaic Acid results in increased expression of CEBPB mRNA
CTD
PMID:28939011
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
G
Ces1d
carboxylesterase 1D
decreases expression
ISO
Okadaic Acid results in decreased expression of CES1D mRNA
CTD
PMID:25270620
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
G
Cfap251
cilia and flagella associated protein 251
decreases expression
ISO
Okadaic Acid results in decreased expression of WDR66 mRNA
CTD
PMID:25270620
NCBI chr12:38,708,915...38,781,598
Ensembl chr12:38,709,595...38,782,010
G
Cfl1
cofilin 1
increases expression
ISO
Okadaic Acid results in increased expression of CFL1 protein
CTD
PMID:19397276
NCBI chr 1:220,869,805...220,873,337
Ensembl chr 1:220,869,805...220,873,337
G
Cftr
CF transmembrane conductance regulator
decreases activity
ISO
Okadaic Acid results in decreased activity of CFTR protein
CTD
PMID:15936019
NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
G
Chchd3
coiled-coil-helix-coiled-coil-helix domain containing 3
decreases expression
ISO
Okadaic Acid results in decreased expression of CHCHD3 protein
CTD
PMID:19397276
NCBI chr 4:60,080,536...60,358,592
Ensembl chr 4:60,080,538...60,358,562
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[PNU-282987 binds to and results in increased activity of CHRNA7 protein] which results in decreased susceptibility to Okadaic Acid]; [[1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea affects the activity of CHRNA7 protein] which results in increased uptake of Calcium] inhibits the reaction [CHRNA7 protein results in decreased susceptibility to Okadaic Acid]; [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]; [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]; [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]; [PNU-282987 binds to and results in increased activity of CHRNA7 protein] which results in decreased susceptibility to Okadaic Acid; JAK2 protein affects the reaction [[PNU-282987 binds to and results in increased activity of CHRNA7 protein] which results in decreased susceptibility to Okadaic Acid]
CTD
PMID:21715663
NCBI chr 1:123,897,341...124,039,263
Ensembl chr 1:123,899,657...124,039,196
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] which results in decreased susceptibility to Okadaic Acid]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] which results in decreased susceptibility to Okadaic Acid]; [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]; [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]; [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]; [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] which results in decreased susceptibility to Okadaic Acid; Calcium affects the reaction [[5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] which results in decreased susceptibility to Okadaic Acid]
CTD
PMID:21715663
NCBI chr 2:189,088,570...189,096,785
Ensembl chr 2:189,088,570...189,096,785
G
Cldn2
claudin 2
increases expression
ISO
Okadaic Acid results in increased expression of CLDN2 mRNA
CTD
PMID:30926360
NCBI chr X:111,122,552...111,133,188
Ensembl chr X:111,122,552...111,137,769
G
Cldn4
claudin 4
increases expression
ISO
Okadaic Acid results in increased expression of CLDN4 mRNA
CTD
PMID:30926360
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
G
Cldn7
claudin 7
increases expression
ISO
Okadaic Acid results in increased expression of CLDN7 mRNA
CTD
PMID:30926360
NCBI chr10:56,576,326...56,578,632
Ensembl chr10:56,576,428...56,578,626
G
Clns1a
chloride nucleotide-sensitive channel 1A
decreases expression
ISO
Okadaic Acid results in decreased expression of CLNS1A protein
CTD
PMID:19397276
NCBI chr 1:162,676,246...162,696,549
Ensembl chr 1:162,676,269...162,696,544
G
Clta
clathrin, light chain A
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CLTA mRNA
CTD
PMID:19840844
NCBI chr 5:59,490,689...59,509,139
Ensembl chr 5:59,491,096...59,509,138
G
Clu
clusterin
increases expression
ISO
Okadaic Acid results in increased expression of CLU mRNA
CTD
PMID:23561263
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
G
Col1a1
collagen type I alpha 1 chain
increases expression
EXP
Okadaic Acid results in increased expression of COL1A1 mRNA
CTD
PMID:8997264
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL1A2 mRNA
CTD
PMID:19840844
NCBI chr 4:31,534,225...31,569,152
Ensembl chr 4:31,534,225...31,569,151
G
Col6a1
collagen type VI alpha 1 chain
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL6A1 mRNA
CTD
PMID:19840844
NCBI chr20:12,657,913...12,676,370
Ensembl chr20:12,658,065...12,675,561
G
Col8a1
collagen type VIII alpha 1 chain
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL8A1 mRNA
CTD
PMID:19840844
NCBI chr11:44,877,690...45,006,203
Ensembl chr11:44,877,859...45,007,891
G
Comt
catechol-O-methyltransferase
decreases expression multiple interactions
ISO
Okadaic Acid results in decreased expression of COMT protein [Okadaic Acid co-treated with gambierol] results in decreased expression of COMT protein
CTD
PMID:19397276
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
G
Coq3
coenzyme Q3 methyltransferase
increases expression
ISO
Okadaic Acid results in increased expression of COQ3 mRNA
CTD
PMID:25270620
NCBI chr 5:36,024,673...36,056,664
Ensembl chr 5:36,024,649...36,056,669
G
Cpne9
copine family member 9
decreases expression
ISO
Okadaic Acid results in decreased expression of CPNE9 mRNA
CTD
PMID:25270620
NCBI chr 4:145,238,011...145,262,444
Ensembl chr 4:145,238,947...145,262,442
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
Okadaic Acid inhibits the reaction [resveratrol inhibits the reaction [Colforsin results in increased phosphorylation of CREB1 protein]]
CTD
PMID:23292070
NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
G
Crebbp
CREB binding protein
increases phosphorylation increases expression
ISO
Okadaic Acid results in increased phosphorylation of CREBBP protein Okadaic Acid results in increased expression of CREBBP mRNA
CTD
PMID:16059639 PMID:28939011
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
G
Ctnnb1
catenin beta 1
increases phosphorylation increases expression multiple interactions
ISO
Okadaic Acid results in increased phosphorylation of CTNNB1 protein Okadaic Acid results in increased expression of CTNNB1 mRNA Okadaic Acid promotes the reaction [CTNNB1 protein binds to CDH1 protein]; Okadaic Acid promotes the reaction [CTNNB1 protein binds to CTNNBIP1 protein]; Okadaic Acid promotes the reaction [CTNNB1 protein binds to TCF4 protein]; Okadaic Acid results in increased activity of and results in decreased phosphorylation of CTNNB1 protein; Okadaic Acid results in increased expression of and affects the localization of CTNNB1 protein
CTD
PMID:16878161 PMID:31115591
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Ctnnbip1
catenin, beta-interacting protein 1
multiple interactions
ISO
Okadaic Acid promotes the reaction [CTNNB1 protein binds to CTNNBIP1 protein]
CTD
PMID:31115591
NCBI chr 5:166,464,170...166,513,030
Ensembl chr 5:166,464,252...166,513,027
G
Ctsb
cathepsin B
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of CTSB mRNA
CTD
PMID:19840844
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
G
Ctsl
cathepsin L
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CTSL mRNA
CTD
PMID:19840844
NCBI chr17:1,873,105...1,879,266
Ensembl chr17:1,872,848...1,879,279
G
Cxcl12
C-X-C motif chemokine ligand 12
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CXCL12 mRNA
CTD
PMID:19840844
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP ISO
CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Okadaic Acid
CTD
PMID:26374342
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
Okadaic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]
CTD
PMID:10696073
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
multiple interactions
EXP ISO
Okadaic Acid inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP2B1 mRNA]; Okadaic Acid inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP2B1 protein]; Okadaic Acid inhibits the reaction [2,4,4'-trichlorobiphenyl results in increased expression of CYP2B1 mRNA]; Okadaic Acid inhibits the reaction [2,4,4'-trichlorobiphenyl results in increased expression of CYP2B1 protein]; Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP2B1 mRNA]; Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP2B1 protein]; Okadaic Acid inhibits the reaction [2,4,5,2',5'-pentachlorobiphenyl results in increased expression of CYP2B1 mRNA]; Okadaic Acid inhibits the reaction [2,4,5,2',5'-pentachlorobiphenyl results in increased expression of CYP2B1 protein]; Okadaic Acid inhibits the reaction [2,5,2',5'-tetrachlorobiphenyl results in increased expression of CYP2B1 mRNA]; Okadaic Acid inhibits the reaction [2,5,2',5'-tetrachlorobiphenyl results in increased expression of CYP2B1 protein]; Okadaic Acid inhibits the reaction [PCB 180 results in increased expression of CYP2B1 mRNA]; Okadaic Acid inhibits the reaction [PCB 180 results in increased expression of CYP2B1 protein]; Okadaic Acid inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA]; Okadaic Acid inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 protein] Okadaic Acid inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA]
CTD
PMID:23770461 PMID:27832320
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases expression
ISO
Okadaic Acid results in decreased expression of CYP2C29 mRNA
CTD
PMID:25270620
NCBI chr 1:147,236,480...147,307,988
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
ISO
Okadaic Acid results in decreased expression of CYP2E1 mRNA
CTD
PMID:25270620
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
EXP
CYP3A2 protein results in increased metabolism of and results in increased hydroxylation of and results in increased susceptibility to Okadaic Acid
CTD
PMID:26374342
NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
multiple interactions
EXP
CYP3A23-3A1 protein results in increased metabolism of and results in increased hydroxylation of and results in decreased susceptibility to Okadaic Acid; Okadaic Acid inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP3A23-3A1 mRNA]; Okadaic Acid inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP3A23-3A1 protein]; Okadaic Acid inhibits the reaction [2,4,4'-trichlorobiphenyl results in increased expression of CYP3A23-3A1 mRNA]; Okadaic Acid inhibits the reaction [2,4,4'-trichlorobiphenyl results in increased expression of CYP3A23-3A1 protein]; Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP3A23-3A1 mRNA]; Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP3A23-3A1 protein]; Okadaic Acid inhibits the reaction [2,4,5,2',5'-pentachlorobiphenyl results in increased expression of CYP3A23-3A1 mRNA]; Okadaic Acid inhibits the reaction [2,4,5,2',5'-pentachlorobiphenyl results in increased expression of CYP3A23-3A1 protein]; Okadaic Acid inhibits the reaction [2,5,2',5'-tetrachlorobiphenyl results in increased expression of CYP3A23-3A1 mRNA]; Okadaic Acid inhibits the reaction [2,5,2',5'-tetrachlorobiphenyl results in increased expression of CYP3A23-3A1 protein]; Okadaic Acid inhibits the reaction [PCB 180 results in increased expression of CYP3A23-3A1 mRNA]; Okadaic Acid inhibits the reaction [PCB 180 results in increased expression of CYP3A23-3A1 protein]; Okadaic Acid inhibits the reaction [Phenobarbital results in increased expression of CYP3A23-3A1 mRNA]; Okadaic Acid inhibits the reaction [Phenobarbital results in increased expression of CYP3A23-3A1 protein]
CTD
PMID:23770461 PMID:26374342
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
multiple interactions decreases response to substance
ISO
CYP3A4 protein results in increased metabolism of and results in increased hydroxylation of and results in decreased susceptibility to Okadaic Acid Okadaic Acid inhibits the reaction [Pregnenolone Carbonitrile results in increased expression of CYP3A11 mRNA] CYP3A4 protein results in decreased susceptibility to Okadaic Acid
CTD
PMID:15710363 PMID:24504163 PMID:26374342
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions
ISO
CYP3A5 protein results in increased metabolism of and results in increased hydroxylation of and results in decreased susceptibility to Okadaic Acid
CTD
PMID:26374342
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
multiple interactions
EXP
Okadaic Acid inhibits the reaction [Dehydroepiandrosterone results in increased expression of CYP4A1 mRNA]; Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA]
CTD
PMID:18079279
NCBI chr 5:134,492,734...134,507,158
Ensembl chr 5:134,492,756...134,507,154
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
Okadaic Acid promotes the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA]; Okadaic Acid promotes the reaction [lithocholic acid acetate results in decreased expression of CYP7A1 mRNA]
CTD
PMID:20371703
NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Okadaic Acid results in increased expression of DDIT3 mRNA
CTD
PMID:28939011
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
G
Ddx1
DEAD-box helicase 1
increases expression
ISO
Okadaic Acid results in increased expression of DDX1 mRNA
CTD
PMID:28939011
NCBI chr 6:38,422,892...38,453,762
Ensembl chr 6:38,422,888...38,453,797
G
Ddx17
DEAD-box helicase 17
decreases expression
ISO
Okadaic Acid results in decreased expression of DDX17 protein
CTD
PMID:19397276
NCBI chr 7:120,761,843...120,765,012
Ensembl chr 7:120,761,826...120,780,641
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
decreases expression
ISO
Okadaic Acid results in decreased expression of DHTKD1 mRNA
CTD
PMID:25270620
NCBI chr17:76,306,585...76,358,058
Ensembl chr17:76,306,585...76,358,058
G
Dlat
dihydrolipoamide S-acetyltransferase
increases expression
ISO
Okadaic Acid results in increased expression of DLAT mRNA
CTD
PMID:28939011
NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
G
Dlg1
discs large MAGUK scaffold protein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of DLG1 mRNA
CTD
PMID:19840844
NCBI chr11:72,164,566...72,378,895
Ensembl chr11:72,163,749...72,378,895
G
Dmp1
dentin matrix acidic phosphoprotein 1
increases expression
ISO
Okadaic Acid results in increased expression of DMP1 mRNA
CTD
PMID:19000923
NCBI chr14:6,889,851...6,923,961
Ensembl chr14:6,889,856...6,900,733
G
Dnajb2
DnaJ heat shock protein family (Hsp40) member B2
increases expression
ISO
Okadaic Acid results in increased expression of DNAJB2 mRNA
CTD
PMID:28939011
NCBI chr 9:82,436,453...82,444,669
Ensembl chr 9:82,436,458...82,444,668
G
Dnajc10
DnaJ heat shock protein family (Hsp40) member C10
increases expression
ISO
Okadaic Acid results in increased expression of DNAJC10 mRNA
CTD
PMID:28939011
NCBI chr 3:67,538,289...67,578,308
Ensembl chr 3:67,538,289...67,578,306
G
Dnajc4
DnaJ heat shock protein family (Hsp40) member C4
decreases expression
ISO
Okadaic Acid results in decreased expression of DNAJC4 mRNA
CTD
PMID:28939011
NCBI chr 1:222,242,889...222,247,115
Ensembl chr 1:222,242,858...222,246,768
G
Dnm1l
dynamin 1-like
increases phosphorylation
EXP
Okadaic Acid results in increased phosphorylation of DNM1L protein
CTD
PMID:26732598
NCBI chr11:88,830,968...88,882,271
Ensembl chr11:88,830,957...88,880,198
G
Dnmt1
DNA methyltransferase 1
multiple interactions
ISO
Okadaic Acid promotes the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of and results in increased activity of DNMT1 protein]
CTD
PMID:23775084
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
G
Dsp
desmoplakin
increases expression
ISO
Okadaic Acid results in increased expression of DSP mRNA
CTD
PMID:25270620
NCBI chr17:27,286,811...27,334,453
Ensembl chr17:27,286,796...27,334,379
G
Dstn
destrin, actin depolymerizing factor
decreases expression
ISO
Okadaic Acid results in decreased expression of DSTN protein
CTD
PMID:19397276
NCBI chr 3:138,024,508...138,051,304
Ensembl chr 3:138,024,508...138,051,298
G
Egf
epidermal growth factor
multiple interactions
EXP
Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of ACO1 protein]; Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of IREB2 protein]
CTD
PMID:10889193
NCBI chr 2:68,820,616...68,895,537
G
Egln1
egl-9 family hypoxia-inducible factor 1
increases expression
ISO
Okadaic Acid results in increased expression of EGLN1 mRNA
CTD
PMID:28939011
NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
G
Egln3
egl-9 family hypoxia-inducible factor 3
increases expression
ISO
Okadaic Acid results in increased expression of EGLN3 mRNA
CTD
PMID:28939011
NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
G
Egr1
early growth response 1
increases expression
ISO
Okadaic Acid results in increased expression of EGR1 mRNA
CTD
PMID:28939011
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation
EXP
Okadaic Acid results in increased phosphorylation of EIF2S1 protein
CTD
PMID:26732598
NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
G
Eln
elastin
multiple interactions decreases expression
EXP
[IL1B protein co-treated with Okadaic Acid] results in decreased expression of ELN mRNA; [Okadaic Acid co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of ELN mRNA; Cycloheximide inhibits the reaction [Okadaic Acid results in decreased expression of ELN mRNA] Okadaic Acid results in decreased expression of ELN mRNA; Okadaic Acid results in decreased expression of ELN protein modified form
CTD
PMID:8997264
NCBI chr12:24,978,478...25,021,864
Ensembl chr12:24,978,483...25,021,863
G
Elob
elongin B
increases expression
ISO
Okadaic Acid results in increased expression of ELOB mRNA
CTD
PMID:28939011
NCBI chr10:13,163,032...13,168,217
Ensembl chr10:13,163,036...13,168,217
G
Eloc
elongin C
increases expression
ISO
Okadaic Acid results in increased expression of ELOC mRNA
CTD
PMID:28939011
NCBI chr 5:2,042,991...2,059,357
Ensembl chr 5:2,042,991...2,059,351
G
Ep300
E1A binding protein p300
decreases expression
ISO
Okadaic Acid results in decreased expression of EP300 mRNA
CTD
PMID:28939011
NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
G
Epas1
endothelial PAS domain protein 1
increases expression
ISO
Okadaic Acid results in increased expression of EPAS1 mRNA
CTD
PMID:28939011
NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
G
Epha5
EPH receptor A5
increases expression
ISO
Okadaic Acid results in increased expression of EPHA5 mRNA
CTD
PMID:25270620
NCBI chr14:25,589,312...25,958,258
Ensembl chr14:25,589,762...25,958,227
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases expression
ISO
Okadaic Acid results in increased expression of ERN1 mRNA
CTD
PMID:28939011
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
EXP
Okadaic Acid results in increased expression of ERO1A protein
CTD
PMID:26732598
NCBI chr15:19,619,947...19,655,381
Ensembl chr15:19,619,973...19,655,381
G
Esr1
estrogen receptor 1
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Okadaic Acid results in increased degradation of ESR1 mRNA]; Okadaic Acid inhibits the reaction [Linoleic Acids, Conjugated results in decreased phosphorylation of ESR1 protein]; Okadaic Acid results in increased degradation of and results in decreased expression of ESR1 mRNA Okadaic Acid results in decreased expression of ESR1 protein
CTD
PMID:15965230 PMID:19800873
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Fas
Fas cell surface death receptor
increases expression
ISO
Okadaic Acid results in increased expression of FAS mRNA
CTD
PMID:31926150
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Fau
FAU, ubiquitin like and ribosomal protein S30 fusion
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of FAU mRNA
CTD
PMID:19840844
NCBI chr 1:221,420,312...221,421,827
Ensembl chr 1:221,420,271...221,421,842
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
decreases expression
ISO
Okadaic Acid results in decreased expression of FDFT1 mRNA
CTD
PMID:28939011
NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
Okadaic Acid results in decreased expression of FDPS mRNA
CTD
PMID:28939011
NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
G
Fgfr4
fibroblast growth factor receptor 4
decreases phosphorylation
ISO
Okadaic Acid results in decreased phosphorylation of FGFR4 protein
CTD
PMID:8576110
NCBI chr17:9,990,072...10,004,339
Ensembl chr17:9,990,078...10,004,321
G
Fis1
fission, mitochondrial 1
increases expression
EXP
Okadaic Acid results in increased expression of FIS1 protein
CTD
PMID:26732598
NCBI chr12:22,750,485...22,765,324
Ensembl chr12:22,750,485...22,765,308
G
Focad
focadhesin
decreases expression
ISO
Okadaic Acid results in decreased expression of FOCAD mRNA
CTD
PMID:25270620
NCBI chr 5:106,409,411...106,729,308
Ensembl chr 5:106,409,456...106,730,684
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP ISO
Okadaic Acid promotes the reaction [Hydrogen Peroxide results in increased expression of FOS protein] Okadaic Acid results in increased expression of FOS mRNA
CTD
PMID:7963561 PMID:15136564 PMID:28939011
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
Okadaic Acid results in increased expression of FOSL1 mRNA
CTD
PMID:19000923 PMID:31115591
NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
G
Foxo3
forkhead box O3
multiple interactions
ISO
Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of FOXO3 protein]]; Okadaic Acid inhibits the reaction [Estradiol inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of FOXO3 protein]]; Okadaic Acid inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of FOXO3 protein]]
CTD
PMID:24954032
NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
G
Fstl1
follistatin-like 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of FSTL1 mRNA
CTD
PMID:19840844
NCBI chr11:65,791,196...65,845,721
Ensembl chr11:65,782,567...65,845,418
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
affects expression
ISO
Okadaic Acid affects the expression of GAPDH mRNA
CTD
PMID:22788371
NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
G
Gimap6
GTPase, IMAP family member 6
increases expression
ISO
Okadaic Acid results in increased expression of GIMAP6 mRNA
CTD
PMID:25270620
NCBI chr 4:78,337,528...78,342,937
Ensembl chr 4:78,336,423...78,342,863
G
Gja1
gap junction protein, alpha 1
increases expression multiple interactions
ISO
Okadaic Acid results in increased expression of GJA1 mRNA [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GJA1 mRNA
CTD
PMID:8597533 PMID:19840844
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
G
Gjb2
gap junction protein, beta 2
increases expression
ISO
Okadaic Acid results in increased expression of GJB2 mRNA
CTD
PMID:8597533
NCBI chr15:37,377,313...37,394,494
Ensembl chr15:37,377,316...37,383,277
G
Gjb5
gap junction protein, beta 5
decreases expression
ISO
Okadaic Acid results in decreased expression of GJB5 mRNA
CTD
PMID:8597533
NCBI chr 5:145,422,034...145,440,558
Ensembl chr 5:145,422,357...145,423,172
G
Glo1
glyoxalase 1
decreases expression multiple interactions
ISO
Okadaic Acid results in decreased expression of GLO1 protein [Okadaic Acid co-treated with gambierol] results in decreased expression of GLO1 protein
CTD
PMID:19397276
NCBI chr20:9,273,589...9,291,608
Ensembl chr20:9,273,594...9,291,610
G
Gpc4
glypican 4
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GPC4 mRNA
CTD
PMID:19840844
NCBI chr X:139,354,325...139,464,876
Ensembl chr X:139,354,155...139,464,798
G
Gpi
glucose-6-phosphate isomerase
increases expression
ISO
Okadaic Acid results in increased expression of GPI mRNA
CTD
PMID:28939011
NCBI chr 1:90,063,411...90,091,287
Ensembl chr 1:90,063,411...90,091,287
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions affects phosphorylation increases expression
ISO
[5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]; [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in decreased susceptibility to Okadaic Acid; [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]; [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]; Okadaic Acid inhibits the reaction [resveratrol results in decreased phosphorylation of GSK3B protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein]]; Lithium Chloride inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein]; Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein] Okadaic Acid results in increased expression of GSK3B protein; Okadaic Acid results in increased expression of GSK3B protein modified form
CTD
PMID:21715663 PMID:23292070 PMID:27050422
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
G
Gsta1
glutathione S-transferase alpha 1
decreases expression
ISO
Okadaic Acid results in decreased expression of GSTA1 mRNA
CTD
PMID:28939011
NCBI chr 9:27,366,404...27,381,004
Ensembl chr 9:27,368,272...27,452,902
G
Gstm1
glutathione S-transferase mu 1
increases expression
ISO
Okadaic Acid results in increased expression of GSTM1 mRNA
CTD
PMID:28939011
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Gstm2
glutathione S-transferase mu 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GSTM2 mRNA
CTD
PMID:19840844
NCBI chr 2:210,778,041...210,782,807
Ensembl chr 2:210,720,704...210,782,856
G
Gstm3
glutathione S-transferase mu 3
increases expression
ISO
Okadaic Acid results in increased expression of GSTM3 mRNA
CTD
PMID:28939011
NCBI chr 2:210,685,204...210,688,273
Ensembl chr 2:210,685,197...210,688,272
G
Gstm5
glutathione S-transferase, mu 5
increases expression
ISO
Okadaic Acid results in increased expression of GSTM3 mRNA
CTD
PMID:28939011
NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
G
Gsto1
glutathione S-transferase omega 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTO1 mRNA
CTD
PMID:19840844
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
G
Gstp1
glutathione S-transferase pi 1
multiple interactions increases expression
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTP1 mRNA Okadaic Acid results in increased expression of GSTP1 mRNA
CTD
PMID:19840844 PMID:28939011
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
H1f4
H1.4 linker histone, cluster member
decreases expression
ISO
Okadaic Acid results in decreased expression of H1-4 mRNA
CTD
PMID:28939011
NCBI chr17:43,734,461...43,735,120
Ensembl chr17:43,734,461...43,735,120
G
Haao
3-hydroxyanthranilate 3,4-dioxygenase
decreases expression
ISO
Okadaic Acid results in decreased expression of HAAO mRNA
CTD
PMID:25270620
NCBI chr 6:7,045,145...7,059,227
Ensembl chr 6:7,045,152...7,058,314
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Okadaic Acid results in increased expression of HIF1A mRNA
CTD
PMID:28939011
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
G
Hist1h2bc
histone cluster 1, H2bc
decreases expression
ISO
Okadaic Acid results in decreased expression of H2BC4 mRNA
CTD
PMID:25270620
NCBI chr17:44,736,184...44,738,393
Ensembl chr17:44,737,950...44,738,330 Ensembl chr17:44,737,950...44,738,330
G
Hk2
hexokinase 2
increases expression
ISO
Okadaic Acid results in increased expression of HK2 mRNA
CTD
PMID:28939011
NCBI chr 4:113,559,396...113,609,897
Ensembl chr 4:113,559,427...113,610,243
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
ISO
Okadaic Acid results in decreased expression of HMGCR mRNA
CTD
PMID:28939011
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
multiple interactions increases expression
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of HPRT mRNA Okadaic Acid results in increased expression of HPRT mRNA
CTD
PMID:19840844 PMID:25270620
NCBI chr X:158,196,640...158,228,815
Ensembl chr X:158,197,149...158,228,749
G
Hspa2
heat shock protein family A (Hsp70) member 2
increases expression
ISO
Okadaic Acid results in increased expression of HSPA2 mRNA
CTD
PMID:28939011
NCBI chr 6:99,433,575...99,436,288
Ensembl chr 6:99,433,550...99,436,289
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
Okadaic Acid results in increased expression of HSPA5 protein
CTD
PMID:26732598
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
G
Hspb1
heat shock protein family B (small) member 1
multiple interactions decreases expression increases expression affects expression
ISO
[Okadaic Acid co-treated with gambierol] affects the expression of HSPB1 protein modified form; [Okadaic Acid co-treated with gambierol] results in increased expression of HSPB1 protein Okadaic Acid results in decreased expression of HSPB1 protein Okadaic Acid results in increased expression of HSPB1 protein Okadaic Acid affects the expression of HSPB1 protein modified form
CTD
PMID:19397276
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
G
Htra2
HtrA serine peptidase 2
affects expression
ISO
Okadaic Acid affects the expression of HTRA2 mRNA
CTD
PMID:28939011
NCBI chr 4:113,883,671...113,886,833
Ensembl chr 4:113,883,670...113,886,994
G
Ier3
immediate early response 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IER3 mRNA
CTD
PMID:19840844
NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Okadaic Acid]
CTD
PMID:10365914
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Il1b
interleukin 1 beta
multiple interactions
ISO EXP
Okadaic Acid inhibits the reaction [IL1B protein results in decreased phosphorylation of RELA protein] [IL1B protein co-treated with Okadaic Acid] results in decreased expression of ELN mRNA Okadaic Acid inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; Okadaic Acid inhibits the reaction [[Lipopolysaccharides co-treated with Nigericin] results in increased expression of IL1B protein]
CTD
PMID:8997264 PMID:11591705 PMID:23430110
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il1rl1
interleukin 1 receptor-like 1
increases expression
ISO
Okadaic Acid results in increased expression of IL1RL1 mRNA
CTD
PMID:19000923
NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
G
Il9
interleukin 9
increases expression
ISO
Okadaic Acid results in increased expression of IL9 mRNA
CTD
PMID:25270620
NCBI chr17:8,558,827...8,561,950
Ensembl chr17:8,558,827...8,561,950
G
Iqcd
IQ motif containing D
increases expression
ISO
Okadaic Acid results in increased expression of IQCD mRNA
CTD
PMID:28939011
NCBI chr12:41,490,451...41,507,416
Ensembl chr12:41,490,801...41,497,610
G
Irak1
interleukin-1 receptor-associated kinase 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IRAK1 mRNA
CTD
PMID:19840844
NCBI chr X:156,716,469...156,726,367
Ensembl chr X:156,716,604...156,725,977
G
Ireb2
iron responsive element binding protein 2
multiple interactions
EXP
Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of IREB2 protein]; Okadaic Acid inhibits the reaction [TRH protein results in decreased activity of IREB2 protein]; Okadaic Acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of IREB2 protein]
CTD
PMID:10889193
NCBI chr 8:59,450,974...59,503,634
Ensembl chr 8:59,420,123...59,501,118
G
Jak2
Janus kinase 2
multiple interactions
ISO
JAK2 protein affects the reaction [[PNU-282987 binds to and results in increased activity of CHRNA7 protein] which results in decreased susceptibility to Okadaic Acid]
CTD
PMID:21715663
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
G
Jpt1
Jupiter microtubule associated homolog 1
affects expression
ISO
Okadaic Acid affects the expression of JPT1 mRNA
CTD
PMID:23561263
NCBI chr10:104,057,739...104,075,776
Ensembl chr10:104,057,697...104,075,777
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
Okadaic Acid inhibits the reaction [Tretinoin results in decreased phosphorylation of JUN protein] Okadaic Acid results in increased expression of JUN mRNA
CTD
PMID:16052510 PMID:19000923 PMID:28939011 PMID:31115591
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Okadaic Acid results in increased expression of JUNB mRNA
CTD
PMID:19000923
NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756
G
Kyat3
kynurenine aminotransferase 3
decreases expression
ISO
Okadaic Acid results in decreased expression of KYAT3 mRNA
CTD
PMID:25270620
NCBI chr 2:248,644,473...248,690,289
Ensembl chr 2:248,649,441...248,690,089
G
Lamc2
laminin subunit gamma 2
increases expression
ISO
Okadaic Acid results in increased expression of LAMC2 mRNA
CTD
PMID:25270620
NCBI chr13:70,566,643...70,632,126
Ensembl chr13:70,566,643...70,626,252
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
Okadaic Acid results in increased expression of LDLR mRNA
CTD
PMID:28939011
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
increases expression
ISO
Okadaic Acid results in increased expression of LGR5 mRNA
CTD
PMID:31115591
NCBI chr 7:58,447,097...58,587,787
Ensembl chr 7:58,448,277...58,587,787
G
LOC100910669
paired immunoglobulin-like type 2 receptor alpha-like
increases expression
ISO
Okadaic Acid results in increased expression of PILRA mRNA
CTD
PMID:25270620
NCBI chr12:21,678,550...21,689,821
Ensembl chr12:21,678,580...21,690,678
G
LOC100912489
histone H4-like
decreases expression
ISO
Okadaic Acid results in decreased expression of H4C3 mRNA
CTD
PMID:28939011
NCBI chr 4:170,144,871...170,145,311
Ensembl chr 4:170,144,951...170,145,262
G
LOC103690190
histone H2A type 1-E
decreases expression
ISO
Okadaic Acid results in decreased expression of H2AC6 mRNA
CTD
PMID:28939011
NCBI chr17:44,747,686...44,748,229
Ensembl chr17:44,747,796...44,748,188 Ensembl chr17:44,747,796...44,748,188
G
Lox
lysyl oxidase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LOX mRNA
CTD
PMID:19840844
NCBI chr18:47,500,320...47,577,819
Ensembl chr18:47,500,330...47,577,819
G
Lpl
lipoprotein lipase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LPL mRNA
CTD
PMID:19840844
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
G
Lrrn1
leucine rich repeat neuronal 1
increases expression
ISO
Okadaic Acid results in increased expression of LRRN1 mRNA
CTD
PMID:25270620
NCBI chr 4:139,633,310...139,679,730
Ensembl chr 4:139,670,092...139,673,143
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
ISO
Okadaic Acid results in increased expression of MANF mRNA
CTD
PMID:28939011
NCBI chr 8:115,623,175...115,626,408
Ensembl chr 8:115,623,178...115,626,380
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
increases expression
ISO
Okadaic Acid results in increased expression of MAP1LC3A mRNA
CTD
PMID:25270620
NCBI chr 3:150,801,289...150,802,935
Ensembl chr 3:150,801,289...150,802,935
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression
ISO
Okadaic Acid results in increased expression of MAP2K3 mRNA
CTD
PMID:28939011
NCBI chr10:45,089,455...45,110,802
Ensembl chr10:47,182,433...47,203,753
G
Map3k10
mitogen activated protein kinase kinase kinase 10
decreases expression
ISO
Okadaic Acid results in decreased expression of MAP3K10 mRNA
CTD
PMID:25270620
NCBI chr 1:84,473,178...84,491,689
Ensembl chr 1:84,473,071...84,491,466
G
Map3k12
mitogen activated protein kinase kinase kinase 12
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MAP3K12 mRNA
CTD
PMID:19840844
NCBI chr 7:144,102,275...144,120,306
Ensembl chr 7:144,102,680...144,109,116
G
Mapk1
mitogen activated protein kinase 1
increases activity increases phosphorylation multiple interactions
EXP ISO
Okadaic Acid results in increased activity of MAPK1 protein Okadaic Acid results in increased phosphorylation of MAPK1 protein Quercetin inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPK1 protein] Okadaic Acid promotes the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of MAPK1 protein]
CTD
PMID:7723735 PMID:19716839 PMID:23335626 PMID:23775084 PMID:27050422
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
increases activity multiple interactions increases phosphorylation
ISO EXP
Okadaic Acid results in increased activity of MAPK3 protein Quercetin inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPK3 protein] Okadaic Acid promotes the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of MAPK3 protein]
CTD
PMID:19716839 PMID:23335626 PMID:23775084 PMID:27050422
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mapk7
mitogen-activated protein kinase 7
multiple interactions
ISO
Okadaic Acid results in increased phosphorylation of and results in increased activity of MAPK7 protein Okadaic Acid results in increased phosphorylation of and results in increased activity of MAPK7 protein; U 0126 inhibits the reaction [Okadaic Acid results in increased phosphorylation of and results in increased activity of MAPK7 protein]
CTD
PMID:19716839
NCBI chr10:47,768,592...47,775,130
Ensembl chr10:47,766,680...47,775,055
G
Mapk8
mitogen-activated protein kinase 8
increases expression
ISO
Okadaic Acid results in increased expression of MAPK8 mRNA
CTD
PMID:28939011
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
G
Mapre2
microtubule-associated protein, RP/EB family, member 2
affects expression
ISO
Okadaic Acid affects the expression of MAPRE2 mRNA
CTD
PMID:23561263
NCBI chr18:14,814,149...15,780,290
G
Mapt
microtubule-associated protein tau
multiple interactions affects phosphorylation increases phosphorylation
ISO EXP
[5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]; [Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein; [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein] Okadaic Acid affects the phosphorylation of MAPT protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lithium Chloride inhibits the reaction [Okadaic Acid affects the phosphorylation of MAPT protein]]; Lithium Chloride inhibits the reaction [Okadaic Acid affects the phosphorylation of MAPT protein]; Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein]; Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of MAPT protein] [Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein; Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein]; Okadaic Acid inhibits the reaction [Potassium Chloride results in decreased phosphorylation of MAPT protein]
CTD
PMID:7723735 PMID:9200503 PMID:21715663 PMID:21934130 PMID:26732598 PMID:27050422
NCBI chr10:92,289,002...92,386,517
Ensembl chr10:92,288,910...92,386,517
G
Marcks
myristoylated alanine rich protein kinase C substrate
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of MARCKS mRNA
CTD
PMID:19840844
NCBI chr20:42,966,140...42,971,838
Ensembl chr20:42,966,140...42,971,838
G
Mars2
methionyl-tRNA synthetase 2, mitochondrial
increases expression
ISO
Okadaic Acid results in increased expression of MARS2 mRNA
CTD
PMID:25270620
NCBI chr 9:64,434,814...64,437,730
Ensembl chr 9:64,434,904...64,436,664 Ensembl chr 9:64,434,904...64,436,664
G
Med1
mediator complex subunit 1
multiple interactions
ISO
[1,25-dihydroxyvitamin D co-treated with Okadaic Acid] promotes the reaction [VDR protein mutant form binds to MED1 protein]
CTD
PMID:16059639
NCBI chr10:86,101,560...86,145,271
Ensembl chr10:86,103,600...86,144,880
G
Mesd
mesoderm development LRP chaperone
decreases expression
ISO
Okadaic Acid results in decreased expression of MESD protein
CTD
PMID:19397276
NCBI chr 1:146,030,211...146,043,097
Ensembl chr 1:146,037,426...146,043,097
G
Mfn1
mitofusin 1
increases expression
EXP
Okadaic Acid results in increased expression of MFN1 protein
CTD
PMID:26732598
NCBI chr 2:118,929,738...118,971,689
Ensembl chr 2:118,929,738...118,973,698
G
Mfn2
mitofusin 2
increases expression
EXP
Okadaic Acid results in increased expression of MFN2 protein
CTD
PMID:26732598
NCBI chr 5:164,684,244...164,715,414
Ensembl chr 5:164,684,509...164,714,145
G
Mgst3
microsomal glutathione S-transferase 3
multiple interactions increases expression
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MGST3 mRNA Okadaic Acid results in increased expression of MGST3 mRNA
CTD
PMID:19840844 PMID:28939011
NCBI chr13:85,601,499...85,622,392
Ensembl chr13:85,601,499...85,622,314
G
Mllt11
MLLT11, transcription factor 7 cofactor
decreases expression
ISO
Okadaic Acid results in decreased expression of MLLT11 mRNA
CTD
PMID:23561263
NCBI chr 2:196,392,936...196,402,106
Ensembl chr 2:196,392,938...196,402,106
G
Mmp1
matrix metallopeptidase 1
increases expression
ISO
Okadaic Acid results in increased expression of MMP1 mRNA
CTD
PMID:28939011
NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MMP2 mRNA
CTD
PMID:19840844
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mob3c
MOB kinase activator 3C
decreases expression
ISO
Okadaic Acid results in decreased expression of MOB3C mRNA
CTD
PMID:25270620
NCBI chr 5:134,679,850...134,687,899
Ensembl chr 5:134,679,713...134,688,963
G
Mphosph6
M phase phosphoprotein 6
increases expression
ISO
Okadaic Acid results in increased expression of MPHOSPH6 mRNA
CTD
PMID:25270620
NCBI chr19:50,357,314...50,367,137
Ensembl chr19:50,357,338...50,367,187
G
Mpp1
membrane palmitoylated protein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of MPP1 mRNA
CTD
PMID:19840844
NCBI chr 1:148,450,213...148,458,945
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
affects expression
ISO
Okadaic Acid affects the expression of COX2 mRNA
CTD
PMID:22788371
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt1
metallothionein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MT1 mRNA
CTD
PMID:19840844
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
G
Mvd
mevalonate diphosphate decarboxylase
decreases expression
ISO
Okadaic Acid results in decreased expression of MVD mRNA
CTD
PMID:28939011
NCBI chr19:55,258,910...55,268,933
Ensembl chr19:55,258,905...55,268,951
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
Okadaic Acid results in increased expression of MYC mRNA
CTD
PMID:31115591
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Myh7
myosin heavy chain 7
multiple interactions
ISO
[Okadaic Acid co-treated with gambierol] results in increased expression of MYH7 protein modified form
CTD
PMID:19397276
NCBI chr15:33,605,769...33,657,761
Ensembl chr15:33,634,422...33,656,089
G
Nans
N-acetylneuraminate synthase
decreases expression
ISO
Okadaic Acid results in decreased expression of NANS protein
CTD
PMID:19397276
NCBI chr 5:62,109,352...62,126,492
Ensembl chr 5:62,109,328...62,126,494
G
Ncor1
nuclear receptor co-repressor 1
decreases activity multiple interactions
ISO
Okadaic Acid results in decreased activity of NCOR1 protein [Tretinoin co-treated with Okadaic Acid] results in decreased activity of NCOR1 protein
CTD
PMID:17312396
NCBI chr10:48,629,121...48,772,890
Ensembl chr10:48,629,121...48,772,890
G
Ncor2
nuclear receptor co-repressor 2
affects localization
EXP
Okadaic Acid affects the localization of NCOR2 protein
CTD
PMID:15773917
NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701
G
Nfe2l2
nuclear factor, erythroid 2-like 2
increases expression
ISO
Okadaic Acid results in increased expression of NFE2L2 protein
CTD
PMID:12446695
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; evodiamine inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein]; Fenretinide inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein]; lonafarnib inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein]; Okadaic Acid inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]]; pregna-4,17-diene-3,16-dione inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein]; zerumbone inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:9973483 PMID:10871845 PMID:15090542 PMID:15322087 PMID:15710601 PMID:16007145 PMID:16230421
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
G
Ngf
nerve growth factor
multiple interactions
EXP
Okadaic Acid promotes the reaction [NGF protein results in increased uptake of Calcium]
CTD
PMID:1374475
NCBI chr 2:204,886,158...204,939,523
Ensembl chr 2:204,886,202...204,940,453
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
multiple interactions decreases expression
ISO
[Okadaic Acid co-treated with gambierol] results in decreased expression of NME1 protein Okadaic Acid results in decreased expression of NME1 protein
CTD
PMID:19397276
NCBI chr10:81,657,152...81,666,542
Ensembl chr10:81,657,153...81,666,523
G
Nop2
NOP2 nucleolar protein
decreases expression
ISO
Okadaic Acid results in decreased expression of NOP2 mRNA
CTD
PMID:25270620
NCBI chr 4:157,646,759...157,658,502
Ensembl chr 4:157,647,082...157,658,390
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Okadaic Acid results in increased activity of NR1I2 protein
CTD
PMID:22206814 PMID:26921727
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
ISO
Okadaic Acid results in decreased expression of NR3C1 mRNA; Okadaic Acid results in decreased expression of NR3C1 protein
CTD
PMID:21533367
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
G
Nts
neurotensin
multiple interactions decreases activity
ISO
Okadaic Acid promotes the reaction [Tetradecanoylphorbol Acetate results in decreased activity of NTS protein] Okadaic Acid results in decreased activity of NTS protein
CTD
PMID:18313772
NCBI chr 7:44,111,594...44,120,998
Ensembl chr 7:44,111,151...44,121,130
G
Nup54
nucleoporin 54
increases expression
ISO
Okadaic Acid results in increased expression of NUP54 mRNA
CTD
PMID:19000923
NCBI chr14:17,123,434...17,141,832
Ensembl chr14:17,123,360...17,141,767
G
Ocln
occludin
increases expression
ISO
Okadaic Acid results in increased expression of OCLN mRNA
CTD
PMID:30926360
NCBI chr 2:30,527,327...30,577,218
Ensembl chr 2:30,527,715...30,577,218
G
Opa1
OPA1, mitochondrial dynamin like GTPase
increases expression
EXP
Okadaic Acid results in increased expression of OPA1 protein
CTD
PMID:26732598
NCBI chr11:74,717,600...74,793,902
Ensembl chr11:74,720,254...74,793,803
G
Orm1
orosomucoid 1
increases expression
ISO
Okadaic Acid results in increased expression of ORM1 mRNA
CTD
PMID:19000923
NCBI chr 5:79,179,668...79,182,820
Ensembl chr 5:79,179,417...79,182,820
G
Osbpl11
oxysterol binding protein-like 11
increases expression
ISO
Okadaic Acid results in increased expression of OSBPL11 mRNA
CTD
PMID:28939011
NCBI chr11:70,770,509...70,855,425
Ensembl chr11:70,770,507...70,833,577
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]
CTD
PMID:16059913
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Pax4
paired box 4
decreases expression
ISO
Okadaic Acid results in decreased expression of PAX4 mRNA
CTD
PMID:25270620
NCBI chr 4:55,735,640...55,753,461
Ensembl chr 4:55,735,682...55,740,627
G
Pcbp1
poly(rC) binding protein 1
decreases expression multiple interactions
ISO
Okadaic Acid results in decreased expression of PCBP1 protein [Okadaic Acid co-treated with gambierol] results in decreased expression of PCBP1 protein
CTD
PMID:19397276
NCBI chr 4:118,327,185...118,329,223
Ensembl chr 4:118,327,533...118,328,602
G
Pcbp2
poly(rC) binding protein 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PCBP2 mRNA
CTD
PMID:19840844
NCBI chr 7:144,077,901...144,103,723
Ensembl chr 7:144,078,496...144,101,893
G
Pcmt1
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1
decreases expression
ISO
Okadaic Acid results in decreased expression of PCMT1 protein
CTD
PMID:19397276
NCBI chr 1:1,734,863...1,767,759
Ensembl chr 1:1,736,276...1,767,618
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PCNA mRNA
CTD
PMID:19840844
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
G
Pdgfra
platelet derived growth factor receptor alpha
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PDGFRA mRNA
CTD
PMID:19840844
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
G
Pdha1
pyruvate dehydrogenase E1 subunit alpha 1
increases expression
ISO
Okadaic Acid results in increased expression of PDHA1 mRNA
CTD
PMID:28939011
NCBI chr X:37,329,779...37,343,410
Ensembl chr X:37,329,779...37,343,410
G
Pdia3
protein disulfide isomerase family A, member 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PDIA3 mRNA
CTD
PMID:19840844
NCBI chr 3:113,376,983...113,400,707
Ensembl chr 3:113,376,983...113,400,707
G
Pdx1
pancreatic and duodenal homeobox 1
multiple interactions
ISO
Okadaic Acid inhibits the reaction [Glucose affects the localization of PDX1 protein]
CTD
PMID:11574405
NCBI chr12:9,496,044...9,501,211
Ensembl chr12:9,496,044...9,501,213
G
Pfdn2
prefoldin subunit 2
increases expression
ISO
Okadaic Acid results in increased expression of PFDN2 mRNA
CTD
PMID:28939011
NCBI chr13:89,725,113...89,743,849
Ensembl chr13:89,725,869...89,743,848
G
Pfdn5
prefoldin subunit 5
increases expression
ISO
Okadaic Acid results in increased expression of PFDN5 mRNA
CTD
PMID:28939011
NCBI chr 7:143,924,662...143,929,400
Ensembl chr 7:143,924,662...143,929,397
G
Pgam1
phosphoglycerate mutase 1
multiple interactions
ISO
[Okadaic Acid co-treated with gambierol] results in decreased expression of PGAM1 protein
CTD
PMID:19397276
NCBI chr 1:261,158,204...261,165,814
Ensembl chr 1:261,158,261...261,165,808
G
Pgr
progesterone receptor
decreases expression
ISO
Okadaic Acid results in decreased expression of PGR mRNA; Okadaic Acid results in decreased expression of PGR protein
CTD
PMID:15965230
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
G
Pias2
protein inhibitor of activated STAT, 2
increases expression
ISO
Okadaic Acid results in increased expression of PIAS2 mRNA
CTD
PMID:25270620
NCBI chr18:73,479,863...73,524,956
Ensembl chr18:73,378,662...73,524,956
G
Pik3r5
phosphoinositide-3-kinase, regulatory subunit 5
increases expression
ISO
Okadaic Acid results in increased expression of PIK3R5 mRNA
CTD
PMID:19000923
NCBI chr10:55,013,686...55,078,986
Ensembl chr10:55,013,703...55,080,421
G
Pilra
paired immunoglobin-like type 2 receptor alpha
increases expression
ISO
Okadaic Acid results in increased expression of PILRA mRNA
CTD
PMID:25270620
NCBI chr12:21,412,598...21,418,621
Ensembl chr12:21,412,538...21,420,169
G
Pla2g4a
phospholipase A2 group IVA
increases expression
ISO
Okadaic Acid results in increased expression of PLA2G4A mRNA
CTD
PMID:25270620
NCBI chr13:67,062,252...67,206,688
Ensembl chr13:66,988,937...67,206,693
G
Plaur
plasminogen activator, urokinase receptor
increases expression
ISO
Okadaic Acid results in increased expression of PLAUR mRNA
CTD
PMID:31115591
NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
G
Podxl
podocalyxin-like
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PODXL mRNA
CTD
PMID:19840844
NCBI chr 4:58,829,049...58,893,353
Ensembl chr 4:58,829,060...58,893,170
G
Polr2a
RNA polymerase II subunit A
increases phosphorylation
ISO
Okadaic Acid results in increased phosphorylation of POLR2A protein
CTD
PMID:8126066
NCBI chr10:56,339,277...56,364,888
Ensembl chr10:56,339,284...56,365,084
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions increases phosphorylation
ISO EXP
Okadaic Acid inhibits the reaction [Nafenopin results in increased activity of PPARA protein]; Okadaic Acid results in increased activity of and results in increased stability of PPARA protein Okadaic Acid results in increased phosphorylation of PPARA protein Okadaic Acid inhibits the reaction [Dehydroepiandrosterone results in decreased phosphorylation of PPARA protein]; Okadaic Acid inhibits the reaction [Dehydroepiandrosterone results in increased activity of PPARA protein]; Okadaic Acid inhibits the reaction [Nafenopin results in decreased phosphorylation of PPARA protein]; Okadaic Acid inhibits the reaction [Nafenopin results in increased activity of PPARA protein mutant form]; Okadaic Acid inhibits the reaction [Nafenopin results in increased activity of PPARA protein]; Okadaic Acid inhibits the reaction [pirinixic acid results in decreased phosphorylation of PPARA protein]
CTD
PMID:15178457 PMID:18079279
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression
ISO
Okadaic Acid results in increased expression of PPARD mRNA
CTD
PMID:31115591
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
G
Ppia
peptidylprolyl isomerase A
decreases expression increases expression
ISO
Okadaic Acid results in decreased expression of PPIA protein Okadaic Acid results in increased expression of PPIA mRNA
CTD
PMID:19397276 PMID:28939011
NCBI chr14:86,673,775...86,677,443
Ensembl chr14:86,673,775...86,677,443
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
multiple interactions decreases activity
ISO EXP
Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of PPP1CA protein] Okadaic Acid results in decreased activity of PPP1CA protein
CTD
PMID:15767308 PMID:16059913
NCBI chr 1:219,439,953...219,443,570
Ensembl chr 1:219,439,953...219,443,570
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
multiple interactions decreases response to substance decreases activity
ISO EXP
[Okadaic Acid results in decreased activity of PPP2CA protein] which results in decreased susceptibility to Dexamethasone; Okadaic Acid inhibits the reaction [arsenic trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]] PPP2CA protein mutant form results in decreased susceptibility to Okadaic Acid
CTD
PMID:15965230 PMID:21655183 PMID:22205926 PMID:29241734
NCBI chr10:37,534,449...37,554,861
Ensembl chr10:37,535,871...37,554,664
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
increases expression
ISO
Okadaic Acid results in increased expression of PPP2R1A protein
CTD
PMID:18937299
NCBI chr 1:60,717,386...60,736,629
Ensembl chr 1:60,717,386...60,736,609
G
Ppp4c
protein phosphatase 4, catalytic subunit
increases expression
ISO
Okadaic Acid results in increased expression of PPP4C mRNA
CTD
PMID:25270620
NCBI chr 1:198,219,012...198,225,775
Ensembl chr 1:198,219,054...198,225,580
G
Prcp
prolylcarboxypeptidase
increases expression
ISO
Okadaic Acid results in increased expression of PRCP mRNA
CTD
PMID:25270620
NCBI chr 1:157,701,089...157,750,177
Ensembl chr 1:157,701,089...157,750,169
G
Prdx4
peroxiredoxin 4
increases expression
ISO
Okadaic Acid results in increased expression of PRDX4 mRNA
CTD
PMID:25270620
NCBI chr X:43,495,453...43,512,994
Ensembl chr X:43,497,763...43,512,991
G
Prdx5
peroxiredoxin 5
multiple interactions decreases expression
ISO
[Okadaic Acid co-treated with gambierol] results in decreased expression of PRDX5 protein Okadaic Acid results in decreased expression of PRDX5 protein
CTD
PMID:19397276
NCBI chr 1:222,164,462...222,167,447
Ensembl chr 1:222,164,462...222,167,447
G
Prdx6
peroxiredoxin 6
multiple interactions
ISO
[Okadaic Acid co-treated with gambierol] results in decreased expression of PRDX6 protein
CTD
PMID:19397276
NCBI chr13:79,077,567...79,088,113
Ensembl chr13:79,077,033...79,088,127
G
Prkg1
protein kinase cGMP-dependent 1
multiple interactions
ISO
[calyculin A co-treated with Okadaic Acid] inhibits the reaction [2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]]
CTD
PMID:23195829
NCBI chr 1:248,982,039...250,300,952
G
Ptger1
prostaglandin E receptor 1
decreases expression
ISO
Okadaic Acid results in decreased expression of PTGER1 mRNA
CTD
PMID:25270620
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Okadaic Acid results in increased expression of PTGS2 mRNA; Okadaic Acid results in increased expression of PTGS2 protein
CTD
PMID:8989914 PMID:9013627 PMID:31115591
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Ptn
pleiotrophin
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PTN mRNA
CTD
PMID:19840844
NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
multiple interactions affects expression
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PTTG1 mRNA Okadaic Acid affects the expression of PTTG1 mRNA
CTD
PMID:19840844 PMID:23561263
NCBI chr10:29,014,332...29,026,088
Ensembl chr10:29,020,049...29,026,002
G
Qars1
glutaminyl-tRNA synthetase 1
affects expression
ISO
Okadaic Acid affects the expression of QARS1 mRNA
CTD
PMID:22788371
NCBI chr 8:117,297,670...117,305,708
Ensembl chr 8:117,297,670...117,305,702
G
Racgap1
Rac GTPase-activating protein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RACGAP1 mRNA
CTD
PMID:19840844
NCBI chr 7:141,277,303...141,308,849
Ensembl chr 7:141,277,312...141,307,233
G
Rad21
RAD21 cohesin complex component
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RAD21 mRNA
CTD
PMID:19840844
NCBI chr 7:91,511,755...91,538,673
Ensembl chr 7:91,511,756...91,538,673
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
multiple interactions
ISO
Okadaic Acid inhibits the reaction [[Hydrogen Peroxide co-treated with Tetradecanoylphorbol Acetate] results in increased activity of RAF1 protein]
CTD
PMID:14623285
NCBI chr 4:147,532,040...147,592,769
Ensembl chr 4:147,532,042...147,592,699
G
Rara
retinoic acid receptor, alpha
multiple interactions
EXP
Okadaic Acid promotes the reaction [alitretinoin results in increased activity of RARA protein]
CTD
PMID:15773917
NCBI chr10:86,838,819...86,884,224
Ensembl chr10:86,860,685...86,884,210
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RB1 protein]
CTD
PMID:12621062
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Rbl1
RB transcriptional corepressor like 1
multiple interactions
ISO
Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein]
CTD
PMID:12621062
NCBI chr 3:153,263,692...153,321,351
Ensembl chr 3:153,263,692...153,321,352
G
Rbl2
RB transcriptional corepressor like 2
multiple interactions
ISO
Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL2 protein]
CTD
PMID:12621062
NCBI chr19:17,300,088...17,346,865
Ensembl chr19:17,300,089...17,346,808
G
Rbx1
ring-box 1
increases expression
ISO
Okadaic Acid results in increased expression of RBX1 mRNA
CTD
PMID:28939011
NCBI chr 7:122,700,849...122,710,907
Ensembl chr 7:122,700,854...122,709,935
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions increases phosphorylation
ISO
anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; evodiamine inhibits the reaction [Okadaic Acid results in increased activity of RELA protein]; Fenretinide inhibits the reaction [Okadaic Acid results in increased activity of RELA protein]; lonafarnib inhibits the reaction [Okadaic Acid results in increased activity of RELA protein]; Okadaic Acid inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]]; Okadaic Acid inhibits the reaction [IL1B protein results in decreased phosphorylation of RELA protein]; pregna-4,17-diene-3,16-dione inhibits the reaction [Okadaic Acid results in increased activity of RELA protein]; zerumbone inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]] Quercetin inhibits the reaction [Okadaic Acid results in increased phosphorylation of RELA protein]
CTD
PMID:9973483 PMID:10871845 PMID:11591705 PMID:15090542 PMID:15322087 PMID:15710601 PMID:16007145 PMID:16230421 PMID:27050422
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Rgs5
regulator of G-protein signaling 5
affects expression
ISO
Okadaic Acid affects the expression of RGS5 mRNA
CTD
PMID:22788371
NCBI chr13:87,966,820...88,002,831
Ensembl chr13:87,966,758...88,003,035
G
Rgs9
regulator of G-protein signaling 9
decreases expression
ISO
Okadaic Acid results in decreased expression of RGS9 mRNA
CTD
PMID:25270620
NCBI chr10:97,509,971...97,582,188
Ensembl chr10:97,509,971...97,582,188
G
Rho
rhodopsin
decreases expression
ISO
Okadaic Acid results in decreased expression of RHO mRNA
CTD
PMID:25270620
NCBI chr 4:147,832,136...147,837,298
Ensembl chr 4:147,832,136...147,837,298
G
Rnf135
ring finger protein 135
decreases expression
ISO
Okadaic Acid results in decreased expression of RNF135 mRNA
CTD
PMID:25270620
NCBI chr10:67,531,989...67,551,237
G
Rpl7
ribosomal protein L7
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RPL7 mRNA
CTD
PMID:19840844
NCBI chr 5:2,633,517...2,636,525
Ensembl chr 5:2,632,712...2,640,021
G
Rps12
ribosomal protein S12
decreases expression
ISO
Okadaic Acid results in decreased expression of RPS12 protein
CTD
PMID:19397276
NCBI chr 1:22,758,214...22,760,370
Ensembl chr 1:22,758,212...22,760,370
G
Rps20
ribosomal protein S20
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RPS20 mRNA
CTD
PMID:19840844
NCBI chr 5:16,706,052...16,707,214
Ensembl chr 5:16,706,082...16,706,909
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions increases phosphorylation
EXP
naringin inhibits the reaction [Okadaic Acid results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:15342961
NCBI chr10:73,824,200...73,865,503
Ensembl chr10:73,824,202...73,865,364
G
Rptn
repetin
increases expression
ISO
Okadaic Acid results in increased expression of RPTN mRNA
CTD
PMID:25270620
NCBI chr 2:193,722,394...193,729,040
Ensembl chr 2:193,724,248...193,728,302
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
[Tretinoin co-treated with alpha-Tocopherol co-treated with Okadaic Acid] results in decreased phosphorylation of RXRA protein
CTD
PMID:15225641
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
G
Sc5d
sterol-C5-desaturase
decreases expression
ISO
Okadaic Acid results in decreased expression of SC5D mRNA
CTD
PMID:28939011
NCBI chr 8:46,525,406...46,537,014
Ensembl chr 8:46,525,400...46,537,050
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
Okadaic Acid results in increased expression of SCARB1 mRNA
CTD
PMID:19000923
NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
G
Sdcbp2
syndecan binding protein 2
increases expression
ISO
Okadaic Acid results in increased expression of SDCBP2 mRNA
CTD
PMID:25270620
NCBI chr 3:147,073,160...147,101,917
Ensembl chr 3:147,073,160...147,101,911
G
Sec63
SEC63 homolog, protein translocation regulator
decreases expression
ISO
Okadaic Acid results in decreased expression of SEC63 mRNA
CTD
PMID:28939011
NCBI chr20:47,494,270...47,563,222
Ensembl chr20:47,494,270...47,563,222
G
Selenop
selenoprotein P
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of SELENOP mRNA
CTD
PMID:19840844
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
G
Semg1
semenogelin 1
decreases expression
ISO
Okadaic Acid results in decreased expression of SEMG1 protein
CTD
PMID:19397276
NCBI chr 3:160,627,609...160,630,457
Ensembl chr 3:160,627,610...160,630,457
G
Sigmar1
sigma non-opioid intracellular receptor 1
increases expression
EXP
Okadaic Acid results in increased expression of SIGMAR1 protein
CTD
PMID:26732598
NCBI chr 5:58,121,824...58,124,687
Ensembl chr 5:58,121,786...58,124,681
G
Slc19a1
solute carrier family 19 member 1
multiple interactions decreases activity
EXP
Okadaic Acid inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] Okadaic Acid results in decreased activity of SLC19A1 protein
CTD
PMID:17482559
NCBI chr20:12,334,675...12,354,517
Ensembl chr20:12,334,676...12,352,377
G
Slc25a4
solute carrier family 25 member 4
affects expression
ISO
Okadaic Acid affects the expression of SLC25A4 mRNA
CTD
PMID:22788371
NCBI chr16:49,266,903...49,270,698
Ensembl chr16:49,266,903...49,270,698
G
Slc2a1
solute carrier family 2 member 1
increases expression
ISO
Okadaic Acid results in increased expression of SLC2A1 mRNA
CTD
PMID:19000923 PMID:28939011
NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
decreases expression
ISO
Okadaic Acid results in decreased expression of SLCO1A2 mRNA
CTD
PMID:31926150
NCBI chr 4:175,969,549...176,026,227
Ensembl chr 4:175,969,549...176,026,163
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions increases response to substance
ISO
Dehydroepiandrosterone Sulfate inhibits the reaction [SLCO1B3 protein results in increased susceptibility to Okadaic Acid]; Okadaic Acid inhibits the reaction [SLCO1B3 protein results in increased uptake of cyanoginosin LR]; Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased susceptibility to Okadaic Acid]; Taurocholic Acid inhibits the reaction [SLCO1B3 protein results in increased susceptibility to Okadaic Acid]
CTD
PMID:26134461
NCBI chr 4:175,814,118...175,881,775
Ensembl chr 4:175,814,118...175,881,768
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
decreases expression
ISO
Okadaic Acid results in decreased expression of SLCO2B1 mRNA
CTD
PMID:31926150
NCBI chr 1:164,623,313...164,671,612
Ensembl chr 1:164,623,599...164,671,577
G
Sod1
superoxide dismutase 1
decreases expression
ISO
Okadaic Acid results in decreased expression of SOD1 protein
CTD
PMID:19397276
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
[Okadaic Acid co-treated with gambierol] results in increased expression of SOD2 protein Okadaic Acid results in increased expression of SOD2 mRNA
CTD
PMID:8037686 PMID:19397276
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
G
Spp1
secreted phosphoprotein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SPP1 mRNA
CTD
PMID:19840844
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
G
Sqle
squalene epoxidase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SQLE mRNA
CTD
PMID:19840844
NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
G
Srebf2
sterol regulatory element binding transcription factor 2
decreases expression
ISO
Okadaic Acid results in decreased expression of SREBF2 mRNA
CTD
PMID:28939011
NCBI chr 7:123,381,082...123,438,605
Ensembl chr 7:123,381,077...123,438,603
G
Srek1ip1
SREK1-interacting protein 1
increases expression
ISO
Okadaic Acid results in increased expression of SREK1IP1 mRNA
CTD
PMID:25270620
NCBI chr 2:34,923,187...34,940,410
G
Ssc5d
scavenger receptor cysteine rich family member with 5 domains
decreases expression
ISO
Okadaic Acid results in decreased expression of SSC5D mRNA
CTD
PMID:25270620
NCBI chr 1:72,443,750...72,462,293
Ensembl chr 1:72,443,758...72,461,547
G
Stard4
StAR-related lipid transfer domain containing 4
decreases expression
ISO
Okadaic Acid results in decreased expression of STARD4 mRNA
CTD
PMID:28939011
NCBI chr18:25,982,210...25,997,555
Ensembl chr18:25,984,638...25,997,555
G
Stmn1
stathmin 1
increases expression
ISO
Okadaic Acid results in increased expression of STMN1 mRNA
CTD
PMID:19000923
NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
G
Stx19
syntaxin 19
decreases expression
ISO
Okadaic Acid results in decreased expression of STX19 mRNA
CTD
PMID:25270620
NCBI chr 7:1,145,002...1,149,978
G
Suclg2
succinate-CoA ligase GDP-forming subunit beta
decreases expression
ISO
Okadaic Acid results in decreased expression of SUCLG2 mRNA
CTD
PMID:25270620
NCBI chr 4:127,552,100...127,824,970
Ensembl chr 4:127,552,101...127,824,970
G
Sumo2
small ubiquitin-like modifier 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SUMO2 mRNA
CTD
PMID:19840844
NCBI chr10:104,085,401...104,097,983
Ensembl chr10:104,086,002...104,097,812
G
Syn1
synapsin I
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SYN1 mRNA
CTD
PMID:19840844
NCBI chr X:1,321,315...1,379,202
Ensembl chr X:1,321,315...1,379,198
G
Tax1bp1
Tax1 binding protein 1
decreases expression
ISO
Okadaic Acid results in decreased expression of TAX1BP1 mRNA
CTD
PMID:23561263
NCBI chr 4:82,776,720...82,832,586
Ensembl chr 4:82,776,746...82,833,773
G
Tceal9
transcription elongation factor A like 9
increases expression
ISO
Okadaic Acid results in increased expression of TCEAL9 mRNA
CTD
PMID:25270620
NCBI chr X:106,791,333...106,794,667
Ensembl chr X:106,791,333...106,794,657
G
Tcf4
transcription factor 4
multiple interactions
ISO
Okadaic Acid promotes the reaction [CTNNB1 protein binds to TCF4 protein]
CTD
PMID:31115591
NCBI chr18:65,285,320...65,507,983
Ensembl chr18:65,155,685...65,507,977
G
Tcp1
t-complex 1
increases expression
ISO
Okadaic Acid results in increased expression of TCP1 mRNA
CTD
PMID:28939011
NCBI chr 1:48,025,664...48,033,343
Ensembl chr 1:48,025,663...48,033,396
G
Tex9
testis expressed 9
increases expression
ISO
Okadaic Acid results in increased expression of TEX9 mRNA
CTD
PMID:25270620
NCBI chr 8:79,083,449...79,119,621
Ensembl chr 8:79,083,522...79,119,720
G
Tf
transferrin
decreases uptake
ISO
Okadaic Acid results in decreased uptake of TF protein
CTD
PMID:16563724
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
G
Tfcp2l1
transcription factor CP2-like 1
increases expression
ISO
Okadaic Acid results in increased expression of TFCP2L1 mRNA
CTD
PMID:25270620
NCBI chr13:34,610,689...34,671,617
Ensembl chr13:34,610,684...34,670,124
G
Tfe3
transcription factor binding to IGHM enhancer 3
multiple interactions
ISO
Okadaic Acid inhibits the reaction [sodium arsenite results in decreased phosphorylation of and affects the localization of TFE3 protein]
CTD
PMID:29945972
NCBI chr X:15,574,579...15,587,826
Ensembl chr X:15,575,934...15,587,419
G
Tfeb
transcription factor EB
multiple interactions
ISO
Okadaic Acid inhibits the reaction [sodium arsenite results in decreased phosphorylation of TFEB protein]
CTD
PMID:29945972
NCBI chr 9:15,208,141...15,264,101
Ensembl chr 9:15,207,822...15,214,596
G
Tfrc
transferrin receptor
increases expression
ISO
Okadaic Acid results in increased expression of TFRC mRNA
CTD
PMID:19000923
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
G
Thbs1
thrombospondin 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of THBS1 mRNA
CTD
PMID:19840844
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
G
Thbs2
thrombospondin 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of THBS2 mRNA
CTD
PMID:19840844
NCBI chr 1:56,653,929...56,683,571
Ensembl chr 1:56,653,938...56,683,731
G
Timp2
TIMP metallopeptidase inhibitor 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of TIMP2 mRNA
CTD
PMID:19840844
NCBI chr10:107,338,465...107,386,072
Ensembl chr10:107,338,465...107,386,072
G
Tjp1
tight junction protein 1
increases expression decreases expression
ISO
Okadaic Acid results in increased expression of TJP1 mRNA Okadaic Acid results in decreased expression of TJP1 protein
CTD
PMID:30926360
NCBI chr 1:126,146,489...126,515,359
Ensembl chr 1:126,146,489...126,227,469
G
Tjp2
tight junction protein 2
increases expression
ISO
Okadaic Acid results in increased expression of TJP2 mRNA
CTD
PMID:30926360
NCBI chr 1:241,945,816...242,084,044
Ensembl chr 1:241,945,841...242,083,484
G
Tlcd1
TLC domain containing 1
increases expression
ISO
Okadaic Acid results in increased expression of TLCD1 mRNA
CTD
PMID:25270620
NCBI chr10:65,439,104...65,441,140
Ensembl chr10:65,439,102...65,444,001
G
Tmed10
transmembrane p24 trafficking protein 10
decreases expression
ISO
Okadaic Acid results in decreased expression of TMED10 mRNA
CTD
PMID:25270620
NCBI chr 6:109,169,739...109,205,004
Ensembl chr 6:109,169,741...109,205,004
G
Tmem45a
transmembrane protein 45A
increases expression
ISO
Okadaic Acid results in increased expression of TMEM45A mRNA
CTD
PMID:25270620
NCBI chr11:46,009,216...46,093,969
Ensembl chr11:46,009,322...46,093,973
G
Tmsb4x
thymosin beta 4, X-linked
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TMSB4X mRNA
CTD
PMID:19840844
NCBI chr X:28,593,405...28,617,267
Ensembl chr X:28,593,405...28,595,395
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO
caffeic acid phenethyl ester inhibits the reaction [Okadaic Acid results in increased expression of TNF protein]; Calcitriol inhibits the reaction [Okadaic Acid results in increased expression of TNF protein]; epigallocatechin gallate inhibits the reaction [Okadaic Acid results in increased expression of TNF protein]; Quercetin inhibits the reaction [Okadaic Acid results in increased expression of TNF protein]; Sulindac inhibits the reaction [Okadaic Acid results in increased expression of TNF protein]; Tamoxifen inhibits the reaction [Okadaic Acid results in increased expression of TNF protein]
CTD
PMID:10757128 PMID:12628509
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]
CTD
PMID:16059913
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
G
Tomm5
translocase of outer mitochondrial membrane 5
affects expression
ISO
Okadaic Acid affects the expression of TOMM5 mRNA
CTD
PMID:22788371
NCBI chr 5:60,655,708...60,658,568
Ensembl chr 5:60,655,379...60,658,535
G
Top2a
DNA topoisomerase II alpha
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TOP2A mRNA
CTD
PMID:19840844
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
G
Tor1a
torsin family 1, member A
increases expression
ISO
Okadaic Acid results in increased expression of TOR1A mRNA
CTD
PMID:28939011
NCBI chr 3:9,800,322...9,807,318
Ensembl chr 3:9,800,322...9,807,328
G
Tp53
tumor protein p53
affects localization affects response to substance multiple interactions decreases expression
ISO
Okadaic Acid affects the localization of TP53 protein TRP53 protein affects the susceptibility to Okadaic Acid Okadaic Acid affects the reaction [Estradiol promotes the reaction [Benzo(a)pyrene affects the localization of TP53 protein]]; Okadaic Acid affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]]; Okadaic Acid inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Benzo(a)pyrene affects the localization of TP53 protein]]; Okadaic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Benzo(a)pyrene affects the localization of TP53 protein]]; Okadaic Acid promotes the reaction [2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]] Okadaic Acid results in decreased expression of TP53 mRNA; Okadaic Acid results in decreased expression of TP53 protein
CTD
PMID:18937299 PMID:20477944 PMID:21512803 PMID:24954032 PMID:31926150
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Trh
thyrotropin releasing hormone
multiple interactions
EXP
Okadaic Acid inhibits the reaction [TRH protein results in decreased activity of ACO1 protein]; Okadaic Acid inhibits the reaction [TRH protein results in decreased activity of IREB2 protein]
CTD
PMID:10889193
NCBI chr 4:124,110,716...124,113,242
Ensembl chr 4:124,110,716...124,113,242
G
Trpc4ap
transient receptor potential cation channel, subfamily C, member 4 associated protein
increases expression
ISO
Okadaic Acid results in increased expression of TRPC4AP mRNA
CTD
PMID:25270620
NCBI chr 3:151,150,396...151,224,123
Ensembl chr 3:151,150,396...151,224,123
G
Tspan13
tetraspanin 13
increases expression
ISO
Okadaic Acid results in increased expression of TSPAN13 mRNA
CTD
PMID:25270620
NCBI chr 6:55,497,659...55,524,415
Ensembl chr 6:55,497,658...55,524,436
G
Ttc3
tetratricopeptide repeat domain 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of TTC3 mRNA
CTD
PMID:19840844
NCBI chr11:34,598,324...34,739,986
Ensembl chr11:34,598,492...34,738,791
G
Txn1
thioredoxin 1
decreases expression multiple interactions
ISO
Okadaic Acid results in decreased expression of TXN protein [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TXN1 mRNA
CTD
PMID:19397276 PMID:19840844
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
G
Ubc
ubiquitin C
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of UBC mRNA
CTD
PMID:19840844
NCBI chr12:36,638,457...36,642,734
Ensembl chr12:36,638,457...36,642,734
G
Ube2d1
ubiquitin-conjugating enzyme E2D 1
increases expression
ISO
Okadaic Acid results in increased expression of UBE2D1 mRNA
CTD
PMID:28939011
NCBI chr20:18,547,370...18,580,291
Ensembl chr20:18,547,370...18,580,291
G
Ube2d3
ubiquitin-conjugating enzyme E2D 3
increases expression
ISO
Okadaic Acid results in increased expression of UBE2D3 mRNA
CTD
PMID:28939011
NCBI chr 2:240,626,198...240,655,874
Ensembl chr 2:240,627,436...240,655,246
G
Ube4b
ubiquitination factor E4B
decreases expression
ISO
Okadaic Acid results in decreased expression of UBE4B mRNA
CTD
PMID:25270620
NCBI chr 5:166,156,033...166,259,069
Ensembl chr 5:166,156,033...166,259,069
G
Ucp2
uncoupling protein 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of UCP2 mRNA
CTD
PMID:19840844
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
G
Uggt1
UDP-glucose glycoprotein glucosyltransferase 1
increases expression
ISO
Okadaic Acid results in increased expression of UGGT1 mRNA
CTD
PMID:28939011
NCBI chr 9:42,692,156...42,805,680
Ensembl chr 9:42,692,105...42,805,673
G
Uqcc2
ubiquinol-cytochrome c reductase complex assembly factor 2
decreases expression
ISO
Okadaic Acid results in decreased expression of UQCC2 mRNA
CTD
PMID:23561263
NCBI chr20:5,712,200...5,723,902
Ensembl chr20:5,712,203...5,723,902
G
Vcp
valosin-containing protein
decreases expression
ISO
Okadaic Acid results in decreased expression of VCP mRNA
CTD
PMID:28939011
NCBI chr 5:58,426,548...58,445,953
Ensembl chr 5:58,426,549...58,445,953
G
Vdr
vitamin D receptor
multiple interactions
ISO
[1,25-dihydroxyvitamin D co-treated with Okadaic Acid] promotes the reaction [VDR protein mutant form binds to MED1 protein]; [1,25-dihydroxyvitamin D co-treated with Okadaic Acid] results in increased activity of VDR protein mutant form
CTD
PMID:16059639
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
Okadaic Acid results in increased expression of VEGFA mRNA
CTD
PMID:19000923 PMID:28939011
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Xbp1
X-box binding protein 1
increases expression
EXP
Okadaic Acid results in increased expression of XBP1 protein
CTD
PMID:26732598
NCBI chr14:85,753,736...85,758,820
Ensembl chr14:85,753,760...85,758,145
G
Xrcc4
X-ray repair cross complementing 4
increases expression
ISO
Okadaic Acid results in increased expression of XRCC4 mRNA
CTD
PMID:25270620
NCBI chr 2:18,674,496...18,927,463
Ensembl chr 2:18,677,220...18,927,365
G
Zdhhc15
zinc finger DHHC-type palmitoyltransferase 15
increases expression
ISO
Okadaic Acid results in increased expression of ZDHHC15 mRNA
CTD
PMID:25270620
NCBI chr X:75,433,957...75,566,531
Ensembl chr X:75,439,778...75,566,481
G
Zdhhc8
zinc finger DHHC-type palmitoyltransferase 8
decreases expression
ISO
Okadaic Acid results in decreased expression of ZDHHC8 mRNA
CTD
PMID:25270620
NCBI chr11:86,903,122...86,917,261
Ensembl chr11:86,903,122...86,915,715
G
Zeb2
zinc finger E-box binding homeobox 2
increases expression
ISO
Okadaic Acid results in increased expression of ZEB2 mRNA
CTD
PMID:19000923
NCBI chr 3:29,857,289...29,985,932
Ensembl chr 3:29,862,473...29,996,865
G
Zfp260
zinc finger protein 260
increases expression
ISO
Okadaic Acid results in increased expression of ZFP260 mRNA
CTD
PMID:25270620
NCBI chr 1:88,452,133...88,465,110
Ensembl chr 1:88,451,958...88,453,578 Ensembl chr 1:88,451,958...88,453,578
G
Abtb2
ankyrin repeat and BTB domain containing 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of ABTB2 mRNA
CTD
PMID:28939011
NCBI chr 3:93,494,706...93,648,750
Ensembl chr 3:93,495,106...93,647,721
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
ISO
dinophysistoxin 1 results in increased expression of ALDOC mRNA
CTD
PMID:28939011
NCBI chr10:65,586,504...65,590,093
Ensembl chr10:65,586,504...65,590,126
G
Atf3
activating transcription factor 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of ATF3 mRNA
CTD
PMID:28939011
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
G
Atxn3
ataxin 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of ATXN3 mRNA
CTD
PMID:28939011
NCBI chr 6:125,817,420...125,853,461
Ensembl chr 6:125,819,640...125,853,461
G
Bace1
beta-secretase 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of BACE1 mRNA
CTD
PMID:28939011
NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
G
Bcl2l11
BCL2 like 11
increases expression
ISO
dinophysistoxin 1 results in increased expression of BCL2L11 mRNA
CTD
PMID:28939011
NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192
G
Bfsp1
beaded filament structural protein 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of BFSP1 mRNA
CTD
PMID:28939011
NCBI chr 3:137,935,345...137,992,652
Ensembl chr 3:137,935,345...137,969,658
G
Bik
BCL2-interacting killer
increases expression
ISO
dinophysistoxin 1 results in increased expression of BIK mRNA
CTD
PMID:28939011
NCBI chr 7:124,390,924...124,410,449
Ensembl chr 7:124,391,432...124,410,447
G
Bpgm
bisphosphoglycerate mutase
increases expression
ISO
dinophysistoxin 1 results in increased expression of BPGM mRNA
CTD
PMID:28939011
NCBI chr 4:61,912,210...61,940,697
Ensembl chr 4:61,912,210...61,940,696
G
Calr
calreticulin
increases expression
ISO
dinophysistoxin 1 results in increased expression of CALR mRNA
CTD
PMID:28939011
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
G
Canx
calnexin
increases expression
ISO
dinophysistoxin 1 results in increased expression of CANX mRNA
CTD
PMID:28939011
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
G
Cck
cholecystokinin
increases expression
ISO
dinophysistoxin 1 results in increased expression of CCK mRNA
CTD
PMID:28939011
NCBI chr 8:130,120,525...130,127,515
Ensembl chr 8:130,120,523...130,127,392
G
Cct4
chaperonin containing TCP1 subunit 4
increases expression
ISO
dinophysistoxin 1 results in increased expression of CCT4 mRNA
CTD
PMID:28939011
NCBI chr14:107,767,392...107,780,270
Ensembl chr14:107,767,392...107,780,270
G
Cct7
chaperonin containing TCP1 subunit 7
increases expression
ISO
dinophysistoxin 1 results in increased expression of CCT7 mRNA
CTD
PMID:28939011
NCBI chr 4:117,235,023...117,252,265
Ensembl chr 4:117,235,023...117,252,265
G
Cd44
CD44 molecule (Indian blood group)
increases expression
ISO
dinophysistoxin 1 results in increased expression of CD44 mRNA
CTD
PMID:28939011
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
increases expression
ISO
dinophysistoxin 1 results in increased expression of CDKN1C mRNA
CTD
PMID:21853993 PMID:28939011
NCBI chr 1:216,661,067...216,663,791
Ensembl chr 1:216,661,080...216,663,721
G
Ceacam1
CEA cell adhesion molecule 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of CEACAM1 mRNA
CTD
PMID:21853993 PMID:28939011
NCBI chr 1:82,327,955...82,344,345
Ensembl chr 1:82,327,955...82,344,345
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
dinophysistoxin 1 results in increased expression of CEBPB mRNA
CTD
PMID:28939011
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
increases expression
ISO
dinophysistoxin 1 results in increased expression of CHRNA7 mRNA
CTD
PMID:28939011
NCBI chr 1:123,897,341...124,039,263
Ensembl chr 1:123,899,657...124,039,196
G
Chst9
carbohydrate sulfotransferase 9
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of CHST9 mRNA
CTD
PMID:28939011
NCBI chr18:6,833,408...7,115,815
Ensembl chr18:6,834,365...7,081,356
G
Crebbp
CREB binding protein
increases expression
ISO
dinophysistoxin 1 results in increased expression of CREBBP mRNA
CTD
PMID:28939011
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
G
Creg2
cellular repressor of E1A-stimulated genes 2
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of CREG2 mRNA
CTD
PMID:28939011
NCBI chr 9:46,328,088...46,402,237
Ensembl chr 9:46,360,061...46,401,911
G
Cryl1
crystallin, lambda 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of CRYL1 mRNA
CTD
PMID:28939011
NCBI chr15:37,543,727...37,663,586
Ensembl chr15:37,543,727...37,663,584
G
Cul2
cullin 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of CUL2 mRNA
CTD
PMID:28939011
NCBI chr17:56,952,480...56,992,716
Ensembl chr17:56,952,480...56,992,694
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
dinophysistoxin 1 results in increased expression of CXCR4 mRNA
CTD
PMID:28939011
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of DDIT3 mRNA
CTD
PMID:28939011
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
dinophysistoxin 1 results in increased expression of DDIT4 mRNA
CTD
PMID:21853993
NCBI chr20:29,509,283...29,511,382
Ensembl chr20:29,509,289...29,511,382
G
Depp1
DEPP1, autophagy regulator
increases expression
ISO
dinophysistoxin 1 results in increased expression of DEPP1 mRNA
CTD
PMID:28939011
NCBI chr 4:148,780,330...148,784,566
Ensembl chr 4:148,782,479...148,784,562
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of DHCR24 mRNA
CTD
PMID:28939011
NCBI chr 5:126,164,708...126,188,926
Ensembl chr 5:126,164,674...126,191,206
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of DHTKD1 mRNA
CTD
PMID:28939011
NCBI chr17:76,306,585...76,358,058
Ensembl chr17:76,306,585...76,358,058
G
Dlat
dihydrolipoamide S-acetyltransferase
increases expression
ISO
dinophysistoxin 1 results in increased expression of DLAT mRNA
CTD
PMID:28939011
NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
G
Dmd
dystrophin
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of DMD mRNA
CTD
PMID:28939011
NCBI chr X:51,149,358...53,519,271
Ensembl chr X:51,286,737...53,519,259
G
Dnajb2
DnaJ heat shock protein family (Hsp40) member B2
increases expression
ISO
dinophysistoxin 1 results in increased expression of DNAJB2 mRNA
CTD
PMID:28939011
NCBI chr 9:82,436,453...82,444,669
Ensembl chr 9:82,436,458...82,444,668
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
ISO
dinophysistoxin 1 results in increased expression of DNAJB9 mRNA
CTD
PMID:28939011
NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
G
Dnajc10
DnaJ heat shock protein family (Hsp40) member C10
increases expression
ISO
dinophysistoxin 1 results in increased expression of DNAJC10 mRNA
CTD
PMID:28939011
NCBI chr 3:67,538,289...67,578,308
Ensembl chr 3:67,538,289...67,578,306
G
Dnajc4
DnaJ heat shock protein family (Hsp40) member C4
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of DNAJC4 mRNA
CTD
PMID:28939011
NCBI chr 1:222,242,889...222,247,115
Ensembl chr 1:222,242,858...222,246,768
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
dinophysistoxin 1 results in increased expression of DUSP4 mRNA
CTD
PMID:28939011
NCBI chr16:61,080,767...61,090,973
Ensembl chr16:61,078,175...61,091,169
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
dinophysistoxin 1 results in increased expression of DUSP5 mRNA
CTD
PMID:28939011
NCBI chr 1:274,245,184...274,258,595
Ensembl chr 1:274,245,184...274,258,595
G
Egln1
egl-9 family hypoxia-inducible factor 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of EGLN1 mRNA
CTD
PMID:28939011
NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
G
Egln2
egl-9 family hypoxia-inducible factor 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of EGLN2 mRNA
CTD
PMID:28939011
NCBI chr 1:83,969,456...83,977,665
Ensembl chr 1:83,969,457...83,977,236
G
Egln3
egl-9 family hypoxia-inducible factor 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of EGLN3 mRNA
CTD
PMID:28939011
NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
G
Egr1
early growth response 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of EGR1 mRNA
CTD
PMID:28939011
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
G
Elob
elongin B
increases expression
ISO
dinophysistoxin 1 results in increased expression of ELOB mRNA
CTD
PMID:28939011
NCBI chr10:13,163,032...13,168,217
Ensembl chr10:13,163,036...13,168,217
G
Eloc
elongin C
increases expression
ISO
dinophysistoxin 1 results in increased expression of ELOC mRNA
CTD
PMID:28939011
NCBI chr 5:2,042,991...2,059,357
Ensembl chr 5:2,042,991...2,059,351
G
Emp1
epithelial membrane protein 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of EMP1 mRNA
CTD
PMID:28939011
NCBI chr 4:169,161,076...169,181,967
Ensembl chr 4:169,147,243...169,181,966
G
Eno2
enolase 2
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of ENO2 mRNA
CTD
PMID:28939011
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
G
Eno3
enolase 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of ENO3 mRNA
CTD
PMID:28939011
NCBI chr10:57,278,271...57,283,661
Ensembl chr10:57,278,307...57,283,653
G
Ep300
E1A binding protein p300
affects expression
ISO
dinophysistoxin 1 affects the expression of EP300 mRNA
CTD
PMID:28939011
NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
G
Epas1
endothelial PAS domain protein 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of EPAS1 mRNA
CTD
PMID:28939011
NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
G
Ephx2
epoxide hydrolase 2
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of EPHX2 mRNA
CTD
PMID:28939011
NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
G
Epsti1
epithelial stromal interaction 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of EPSTI1 mRNA
CTD
PMID:28939011
NCBI chr15:60,084,966...60,190,360
Ensembl chr15:60,084,918...60,190,363
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of ERN1 mRNA
CTD
PMID:28939011
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
G
Ero1b
endoplasmic reticulum oxidoreductase 1 beta
increases expression
ISO
dinophysistoxin 1 results in increased expression of ERO1B mRNA
CTD
PMID:28939011
NCBI chr17:90,709,394...90,783,110
Ensembl chr17:90,710,555...90,756,048
G
F2rl1
F2R like trypsin receptor 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of F2RL1 mRNA
CTD
PMID:28939011
NCBI chr 2:25,222,324...25,235,275
Ensembl chr 2:25,222,328...25,235,275
G
FAM120C
family with sequence similarity 120C
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of FAM120C mRNA
CTD
PMID:28939011
NCBI chr X:20,481,800...21,016,980
Ensembl chr X:20,484,517...21,015,836
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of FDFT1 mRNA
CTD
PMID:28939011
NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of FDPS mRNA
CTD
PMID:28939011
NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
dinophysistoxin 1 results in increased expression of FOS mRNA
CTD
PMID:28939011
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Gpc5
glypican 5
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of GPC5 mRNA
CTD
PMID:28939011
NCBI chr15:100,283,131...101,776,838
G
Gpi
glucose-6-phosphate isomerase
affects expression
ISO
dinophysistoxin 1 affects the expression of GPI mRNA
CTD
PMID:28939011
NCBI chr 1:90,063,411...90,091,287
Ensembl chr 1:90,063,411...90,091,287
G
Gsta1
glutathione S-transferase alpha 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of GSTA1 mRNA
CTD
PMID:28939011
NCBI chr 9:27,366,404...27,381,004
Ensembl chr 9:27,368,272...27,452,902
G
Gsta4
glutathione S-transferase alpha 4
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of GSTA4 mRNA
CTD
PMID:28939011
NCBI chr 8:85,497,557...85,514,732
Ensembl chr 8:85,497,557...85,518,879
G
Gstk1
glutathione S-transferase kappa 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of GSTK1 mRNA
CTD
PMID:28939011
NCBI chr 4:71,621,777...71,626,096
Ensembl chr 4:71,621,729...71,626,107
G
Gstm1
glutathione S-transferase mu 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of GSTM1 mRNA
CTD
PMID:28939011
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Gstm3
glutathione S-transferase mu 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of GSTM3 mRNA
CTD
PMID:28939011
NCBI chr 2:210,685,204...210,688,273
Ensembl chr 2:210,685,197...210,688,272
G
Gstm5
glutathione S-transferase, mu 5
increases expression
ISO
dinophysistoxin 1 results in increased expression of GSTM3 mRNA
CTD
PMID:28939011
NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
G
Gstp1
glutathione S-transferase pi 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of GSTP1 mRNA
CTD
PMID:28939011
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
Gstz1
glutathione S-transferase zeta 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of GSTZ1 mRNA
CTD
PMID:28939011
NCBI chr 6:111,176,798...111,187,246
Ensembl chr 6:111,176,798...111,187,244
G
H1f4
H1.4 linker histone, cluster member
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of H1-4 mRNA
CTD
PMID:28939011
NCBI chr17:43,734,461...43,735,120
Ensembl chr17:43,734,461...43,735,120
G
Hebp1
heme binding protein 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of HEBP1 mRNA
CTD
PMID:28939011
NCBI chr 4:168,903,586...168,933,102
Ensembl chr 4:168,903,565...168,933,079
G
Hif1a
hypoxia inducible factor 1 subunit alpha
affects expression
ISO
dinophysistoxin 1 affects the expression of HIF1A mRNA
CTD
PMID:28939011
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
G
Hif1an
hypoxia inducible factor 1 subunit alpha inhibitor
increases expression
ISO
dinophysistoxin 1 results in increased expression of HIF1AN mRNA
CTD
PMID:28939011
NCBI chr 1:264,309,214...264,319,269
Ensembl chr 1:264,309,214...264,319,267
G
Hif3a
hypoxia inducible factor 3 subunit alpha
affects expression
ISO
dinophysistoxin 1 affects the expression of HIF3A mRNA
CTD
PMID:28939011
NCBI chr 1:78,976,318...78,997,869
Ensembl chr 1:78,976,318...78,997,869
G
Hk1
hexokinase 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of HK1 mRNA
CTD
PMID:28939011
NCBI chr20:31,911,460...31,979,780
Ensembl chr20:31,912,262...31,956,649
G
Hk2
hexokinase 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of HK2 mRNA
CTD
PMID:28939011
NCBI chr 4:113,559,396...113,609,897
Ensembl chr 4:113,559,427...113,610,243
G
Hmgcl
3-hydroxy-3-methylglutaryl-CoA lyase
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of HMGCL mRNA
CTD
PMID:28939011
NCBI chr 5:154,294,841...154,308,582
Ensembl chr 5:154,294,806...154,308,640
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of HMGCR mRNA
CTD
PMID:28939011
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
G
Hspa2
heat shock protein family A (Hsp70) member 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of HSPA2 mRNA
CTD
PMID:28939011
NCBI chr 6:99,433,575...99,436,288
Ensembl chr 6:99,433,550...99,436,289
G
Htra2
HtrA serine peptidase 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of HTRA2 mRNA
CTD
PMID:28939011
NCBI chr 4:113,883,671...113,886,833
Ensembl chr 4:113,883,670...113,886,994
G
Ier3
immediate early response 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of IER3 mRNA
CTD
PMID:28939011
NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
G
Iqcd
IQ motif containing D
increases expression
ISO
dinophysistoxin 1 results in increased expression of IQCD mRNA
CTD
PMID:28939011
NCBI chr12:41,490,451...41,507,416
Ensembl chr12:41,490,801...41,497,610
G
Irs2
insulin receptor substrate 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of IRS2 mRNA
CTD
PMID:28939011
NCBI chr16:83,824,515...83,848,569
Ensembl chr16:83,824,430...83,848,684
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
dinophysistoxin 1 results in increased expression of JUN mRNA
CTD
PMID:28939011
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Kcnj16
potassium inwardly-rectifying channel, subfamily J, member 16
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of KCNJ16 mRNA
CTD
PMID:28939011
NCBI chr10:99,330,894...99,391,551
Ensembl chr10:99,388,130...99,389,898
G
Klf4
Kruppel like factor 4
increases expression
ISO
dinophysistoxin 1 results in increased expression of KLF4 mRNA
CTD
PMID:28939011
NCBI chr 5:72,283,311...72,287,669
Ensembl chr 5:72,283,313...72,287,669
G
Lama1
laminin subunit alpha 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of LAMA1 mRNA
CTD
PMID:28939011
NCBI chr 9:115,916,907...116,042,123
Ensembl chr 9:115,916,907...116,042,123
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
dinophysistoxin 1 results in increased expression of LDLR mRNA
CTD
PMID:28939011
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
G
Lfng
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
increases expression
ISO
dinophysistoxin 1 results in increased expression of LFNG mRNA
CTD
PMID:28939011
NCBI chr12:16,117,767...16,126,211
Ensembl chr12:16,118,634...16,126,953
G
Lgsn
lengsin, lens protein with glutamine synthetase domain
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of LGSN mRNA
CTD
PMID:28939011
NCBI chr 9:37,458,603...37,490,117
Ensembl chr 9:37,462,693...37,490,108
G
LOC100912489
histone H4-like
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of H4C3 mRNA
CTD
PMID:28939011
NCBI chr 4:170,144,871...170,145,311
Ensembl chr 4:170,144,951...170,145,262
G
LOC103690190
histone H2A type 1-E
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of H2AC6 mRNA
CTD
PMID:28939011
NCBI chr17:44,747,686...44,748,229
Ensembl chr17:44,747,796...44,748,188 Ensembl chr17:44,747,796...44,748,188
G
Lyrm9
LYR motif containing 9
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of LYRM9 mRNA
CTD
PMID:28939011
NCBI chr10:66,099,478...66,113,559
Ensembl chr10:66,099,531...66,113,559
G
Mab21l4
mab-21 like 4
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of MAB21L4 mRNA
CTD
PMID:28939011
NCBI chr 9:100,296,780...100,307,415
Ensembl chr 9:100,296,781...100,306,829
G
Mafb
MAF bZIP transcription factor B
increases expression
ISO
dinophysistoxin 1 results in increased expression of MAFB mRNA
CTD
PMID:21853993 PMID:28939011
NCBI chr 3:156,338,993...156,340,913
Ensembl chr 3:156,339,004...156,340,913
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
ISO
dinophysistoxin 1 results in increased expression of MANF mRNA
CTD
PMID:28939011
NCBI chr 8:115,623,175...115,626,408
Ensembl chr 8:115,623,178...115,626,380
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of MAP2K3 mRNA
CTD
PMID:28939011
NCBI chr10:45,089,455...45,110,802
Ensembl chr10:47,182,433...47,203,753
G
Mapk8
mitogen-activated protein kinase 8
increases expression
ISO
dinophysistoxin 1 results in increased expression of MAPK8 mRNA
CTD
PMID:28939011
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
G
Mdh1
malate dehydrogenase 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of MDH1 mRNA
CTD
PMID:28939011
NCBI chr14:106,378,349...106,393,642
Ensembl chr14:106,378,942...106,393,670
G
Mdh2
malate dehydrogenase 2
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of MDH2 mRNA
CTD
PMID:28939011
NCBI chr12:23,941,451...23,954,406
Ensembl chr12:23,941,448...23,954,431
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of MGST1 mRNA
CTD
PMID:28939011
NCBI chr 4:172,119,382...172,134,609
Ensembl chr 4:172,119,331...172,134,607
G
Mgst3
microsomal glutathione S-transferase 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of MGST3 mRNA
CTD
PMID:28939011
NCBI chr13:85,601,499...85,622,392
Ensembl chr13:85,601,499...85,622,314
G
Mmp1
matrix metallopeptidase 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of MMP1 mRNA
CTD
PMID:28939011
NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
G
Mvd
mevalonate diphosphate decarboxylase
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of MVD mRNA
CTD
PMID:28939011
NCBI chr19:55,258,910...55,268,933
Ensembl chr19:55,258,905...55,268,951
G
Myo5c
myosin VC
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of MYO5C mRNA
CTD
PMID:28939011
NCBI chr 8:82,171,296...82,248,109
Ensembl chr 8:82,171,497...82,247,544
G
Neurl1b
neuralized E3 ubiquitin protein ligase 1B
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of NEURL1B mRNA
CTD
PMID:28939011
NCBI chr10:17,048,251...17,075,139
Ensembl chr10:17,048,251...17,075,139
G
Nmnat3
nicotinamide nucleotide adenylyltransferase 3
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of NMNAT3 mRNA
CTD
PMID:28939011
NCBI chr 8:106,317,038...106,429,535
Ensembl chr 8:106,317,124...106,429,522
G
Nppb
natriuretic peptide B
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of NPPB mRNA
CTD
PMID:21853993 PMID:28939011
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of NR2F2 mRNA
CTD
PMID:28939011
NCBI chr 1:131,447,671...131,465,749
Ensembl chr 1:131,448,447...131,460,473
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of NR4A1 mRNA
CTD
PMID:28939011
NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
G
Nrip3
nuclear receptor interacting protein 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of NRIP3 mRNA
CTD
PMID:28939011
NCBI chr 1:174,385,424...174,411,141
Ensembl chr 1:174,385,424...174,411,141
G
Ntn4
netrin 4
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of NTN4 mRNA
CTD
PMID:28939011
NCBI chr 7:34,533,543...34,649,330
Ensembl chr 7:34,533,543...34,649,481
G
Ogdhl
oxoglutarate dehydrogenase L
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of OGDHL mRNA
CTD
PMID:28939011
NCBI chr16:8,497,495...8,523,552
Ensembl chr16:8,497,569...8,523,557
G
Osr2
odd-skipped related transciption factor 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of OSR2 mRNA
CTD
PMID:21853993
NCBI chr 7:74,047,820...74,055,096
Ensembl chr 7:74,047,814...74,055,256
G
Palm3
paralemmin 3
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of PALM3 mRNA
CTD
PMID:28939011
NCBI chr19:25,143,464...25,152,275
Ensembl chr19:25,143,428...25,151,891
G
Pdgfrl
platelet-derived growth factor receptor-like
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of PDGFRL mRNA
CTD
PMID:28939011
NCBI chr16:54,386,269...54,450,426
Ensembl chr16:54,386,288...54,450,426
G
Pdha1
pyruvate dehydrogenase E1 subunit alpha 1
affects expression
ISO
dinophysistoxin 1 affects the expression of PDHA1 mRNA
CTD
PMID:28939011
NCBI chr X:37,329,779...37,343,410
Ensembl chr X:37,329,779...37,343,410
G
Pdzk1
PDZ domain containing 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of PDZK1 mRNA
CTD
PMID:28939011
NCBI chr 2:198,965,685...198,999,323
Ensembl chr 2:198,965,685...198,999,323
G
Pfdn2
prefoldin subunit 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of PFDN2 mRNA
CTD
PMID:28939011
NCBI chr13:89,725,113...89,743,849
Ensembl chr13:89,725,869...89,743,848
G
Pfkm
phosphofructokinase, muscle
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of PFKM mRNA
CTD
PMID:28939011
NCBI chr 7:139,702,066...139,722,132
Ensembl chr 7:139,685,573...139,722,132
G
Pgm1
phosphoglucomutase 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of PGM1 mRNA
CTD
PMID:28939011
NCBI chr 5:118,743,632...118,803,055
Ensembl chr 5:118,743,632...118,803,055
G
Phlda2
pleckstrin homology-like domain, family A, member 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of PHLDA2 mRNA
CTD
PMID:28939011
NCBI chr 1:216,701,345...216,704,479
Ensembl chr 1:216,702,319...216,703,534
G
Pigz
phosphatidylinositol glycan anchor biosynthesis, class Z
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of PIGZ mRNA
CTD
PMID:28939011
NCBI chr11:72,930,040...72,936,002
Ensembl chr11:72,931,297...72,934,823 Ensembl chr11:72,931,297...72,934,823
G
Plau
plasminogen activator, urokinase
increases expression
ISO
dinophysistoxin 1 results in increased expression of PLAU mRNA
CTD
PMID:28939011
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
G
Plaur
plasminogen activator, urokinase receptor
increases expression
ISO
dinophysistoxin 1 results in increased expression of PLAUR mRNA
CTD
PMID:28939011
NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
G
Plk2
polo-like kinase 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of PLK2 mRNA
CTD
PMID:28939011
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
G
Plk3
polo-like kinase 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of PLK3 mRNA
CTD
PMID:28939011
NCBI chr 5:135,997,725...136,002,900
Ensembl chr 5:135,997,725...136,002,900
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
dinophysistoxin 1 results in increased expression of PPP1R15A mRNA
CTD
PMID:28939011
NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
G
Rasd1
ras related dexamethasone induced 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of RASD1 mRNA
CTD
PMID:28939011
NCBI chr10:46,330,361...46,339,326
Ensembl chr10:46,330,368...46,332,172
G
Rbks
ribokinase
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of RBKS mRNA
CTD
PMID:28939011
NCBI chr 6:26,051,568...26,128,762
Ensembl chr 6:26,051,396...26,128,906
G
Rbx1
ring-box 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of RBX1 mRNA
CTD
PMID:28939011
NCBI chr 7:122,700,849...122,710,907
Ensembl chr 7:122,700,854...122,709,935
G
Reep1
receptor accessory protein 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of REEP1 mRNA
CTD
PMID:28939011
NCBI chr 4:99,618,622...99,735,329
Ensembl chr 4:99,618,622...99,735,319
G
RGD1564664
similar to LOC387763 protein
increases expression
ISO
dinophysistoxin 1 results in increased expression of C11ORF96 mRNA
CTD
PMID:28939011
NCBI chr 3:82,854,779...82,856,171
Ensembl chr 3:82,854,777...82,856,171
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
dinophysistoxin 1 results in increased expression of RGS16 mRNA
CTD
PMID:21853993 PMID:28939011
NCBI chr13:71,163,411...71,185,147
Ensembl chr13:71,179,910...71,185,216
G
Rhoc
ras homolog family member C
increases expression
ISO
dinophysistoxin 1 results in increased expression of RHOC mRNA
CTD
PMID:28939011
NCBI chr 2:207,271,692...207,278,010
Ensembl chr 2:207,271,853...207,279,314
G
Rnf128
ring finger protein 128
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of RNF128 mRNA
CTD
PMID:28939011
NCBI chr X:110,789,061...110,877,964
Ensembl chr X:110,789,269...110,877,978
G
Rps27a
ribosomal protein S27a
increases expression
ISO
dinophysistoxin 1 results in increased expression of RPS27A mRNA
CTD
PMID:28939011
NCBI chr14:113,966,163...113,968,440
Ensembl chr14:113,966,611...113,968,268 Ensembl chr 5:113,966,611...113,968,268
G
Sc5d
sterol-C5-desaturase
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of SC5D mRNA
CTD
PMID:28939011
NCBI chr 8:46,525,406...46,537,014
Ensembl chr 8:46,525,400...46,537,050
G
Serpinb8
serpin family B member 8
increases expression
ISO
dinophysistoxin 1 results in increased expression of SERPINB8 mRNA
CTD
PMID:28939011
NCBI chr13:27,876,662...27,914,038
Ensembl chr13:27,889,345...27,914,006
G
Serpine2
serpin family E member 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of SERPINE2 mRNA
CTD
PMID:28939011
NCBI chr 9:85,560,852...85,629,410
Ensembl chr 9:85,560,863...85,626,094
G
Sil1
SIL1 nucleotide exchange factor
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of SIL1 mRNA
CTD
PMID:28939011
NCBI chr18:28,067,476...28,302,008
Ensembl chr18:28,067,484...28,301,863
G
Slc16a3
solute carrier family 16 member 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of SLC16A3 mRNA
CTD
PMID:28939011
NCBI chr10:110,138,519...110,148,360
Ensembl chr10:110,138,586...110,148,358
G
Slc1a1
solute carrier family 1 member 1
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of SLC1A1 mRNA
CTD
PMID:28939011
NCBI chr 1:246,955,017...247,035,159
Ensembl chr 1:246,954,980...247,037,056
G
Slc2a1
solute carrier family 2 member 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of SLC2A1 mRNA
CTD
PMID:28939011
NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
G
Smim14
small integral membrane protein 14
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of SMIM14 mRNA
CTD
PMID:28939011
NCBI chr14:44,413,636...44,460,044
Ensembl chr14:44,413,636...44,457,239
G
Snai1
snail family transcriptional repressor 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of SNAI1 mRNA
CTD
PMID:28939011
NCBI chr 3:164,274,710...164,279,199
Ensembl chr 3:164,274,710...164,279,378
G
Sox8
SRY-box transcription factor 8
increases expression
ISO
dinophysistoxin 1 results in increased expression of SOX8 mRNA
CTD
PMID:28939011
NCBI chr10:14,932,348...14,937,336
Ensembl chr10:14,932,348...14,937,336
G
Srebf2
sterol regulatory element binding transcription factor 2
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of SREBF2 mRNA
CTD
PMID:28939011
NCBI chr 7:123,381,082...123,438,605
Ensembl chr 7:123,381,077...123,438,603
G
Stard4
StAR-related lipid transfer domain containing 4
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of STARD4 mRNA
CTD
PMID:28939011
NCBI chr18:25,982,210...25,997,555
Ensembl chr18:25,984,638...25,997,555
G
Tbc1d8b
TBC1 domain family member 8B
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of TBC1D8B mRNA
CTD
PMID:28939011
NCBI chr X:110,894,831...110,983,269
Ensembl chr X:110,894,845...110,983,309
G
Tcp1
t-complex 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of TCP1 mRNA
CTD
PMID:28939011
NCBI chr 1:48,025,664...48,033,343
Ensembl chr 1:48,025,663...48,033,396
G
Tmem54
transmembrane protein 54
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of TMEM54 mRNA
CTD
PMID:28939011
NCBI chr 5:147,288,700...147,295,191
Ensembl chr 5:147,288,723...147,296,702
G
Tor1a
torsin family 1, member A
increases expression
ISO
dinophysistoxin 1 results in increased expression of TOR1A mRNA
CTD
PMID:28939011
NCBI chr 3:9,800,322...9,807,318
Ensembl chr 3:9,800,322...9,807,328
G
Tpi1
triosephosphate isomerase 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of TPI1 mRNA
CTD
PMID:28939011
NCBI chr 4:157,328,375...157,331,905
Ensembl chr 4:157,328,379...157,331,905
G
Tubb3
tubulin, beta 3 class III
increases expression
ISO
dinophysistoxin 1 results in increased expression of TUBB3 mRNA
CTD
PMID:21853993 PMID:28939011
NCBI chr19:56,220,759...56,229,813
Ensembl chr19:56,220,755...56,229,813
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of UBA52 mRNA
CTD
PMID:28939011
NCBI chr16:20,668,925...20,671,127
Ensembl chr16:20,668,971...20,671,127
G
Ubb
ubiquitin B
increases expression
ISO
dinophysistoxin 1 results in increased expression of UBB mRNA
CTD
PMID:28939011
NCBI chr10:48,880,231...48,881,896
Ensembl chr10:48,881,049...48,881,881
G
Ubc
ubiquitin C
increases expression
ISO
dinophysistoxin 1 results in increased expression of UBC mRNA
CTD
PMID:28939011
NCBI chr12:36,638,457...36,642,734
Ensembl chr12:36,638,457...36,642,734
G
Ube2d1
ubiquitin-conjugating enzyme E2D 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of UBE2D1 mRNA
CTD
PMID:28939011
NCBI chr20:18,547,370...18,580,291
Ensembl chr20:18,547,370...18,580,291
G
Ube2d2
ubiquitin-conjugating enzyme E2D 2
increases expression
ISO
dinophysistoxin 1 results in increased expression of UBE2D2 mRNA
CTD
PMID:28939011
NCBI chr18:28,561,957...28,603,335
Ensembl chr18:28,594,892...28,603,335
G
Ube2d3
ubiquitin-conjugating enzyme E2D 3
increases expression
ISO
dinophysistoxin 1 results in increased expression of UBE2D3 mRNA
CTD
PMID:28939011
NCBI chr 2:240,626,198...240,655,874
Ensembl chr 2:240,627,436...240,655,246
G
Uggt1
UDP-glucose glycoprotein glucosyltransferase 1
increases expression
ISO
dinophysistoxin 1 results in increased expression of UGGT1 mRNA
CTD
PMID:28939011
NCBI chr 9:42,692,156...42,805,680
Ensembl chr 9:42,692,105...42,805,673
G
Vasn
vasorin
increases expression
ISO
dinophysistoxin 1 results in increased expression of VASN mRNA
CTD
PMID:21853993 PMID:28939011
NCBI chr10:11,121,041...11,131,548
Ensembl chr10:11,121,041...11,131,548
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
dinophysistoxin 1 results in increased expression of VEGFA mRNA
CTD
PMID:28939011
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Wnt6
Wnt family member 6
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of WNT6 mRNA
CTD
PMID:28939011
NCBI chr 9:82,033,543...82,047,172
Ensembl chr 9:82,033,543...82,047,166
G
Zc3h6
zinc finger CCCH type containing 6
decreases expression
ISO
dinophysistoxin 1 results in decreased expression of ZC3H6 mRNA
CTD
PMID:28939011
NCBI chr 3:121,497,709...121,554,131
Ensembl chr 3:121,499,195...121,551,433
G
Ccna1
cyclin A1
affects expression
ISO
dinophysistoxin 2 affects the expression of CCNA1 mRNA
CTD
PMID:21512803
NCBI chr 2:144,456,689...144,503,570
Ensembl chr 2:144,458,153...144,467,912
G
Ccnb2
cyclin B2
affects expression
ISO
dinophysistoxin 2 affects the expression of CCNB2 mRNA
CTD
PMID:21512803
NCBI chr 8:76,847,972...76,861,165
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
dinophysistoxin 2 results in decreased expression of CDK2 mRNA
CTD
PMID:21512803
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Tp53
tumor protein p53
affects localization
ISO
dinophysistoxin 2 affects the localization of TP53 protein
CTD
PMID:21512803
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all